FR2936707A1 - Composition, useful e.g. for cosmetically treating skin, lips, hair, eyelashes, and scalp, comprises in a medium at least one UV filter system, at least one dibenzoylmethane derivative and at least one dithiolane silyl compound - Google Patents

Abstract

Composition (A) comprises in a medium at least one UV filter system, at least one dibenzoylmethane derivative (1a) and at least one dithiolane silyl compound (I). Composition (A) comprises in a medium at least one UV filter system, at least one dibenzoylmethane derivative (1a) and at least one dithiolane silyl compound of formula (I). m : 0-8; X : O, N or S; Y 1O, N, S or NR 4; v : 0-10; R 1-R 31-10C linear or 3-10C branched optionally saturated alkyl, which may include one or more halo, phenyl or benzyl; D : 1-8C linear or 2-8C branched optionally saturated alkyl, phenyl or Si(CH 3) 3; W 11-8C linear or 3-8C branched, optionally saturated alky, or 2-8C alkylene optionally substituted by OH; and R 4H or 1-20C linear or 3-20C branched, optionally saturated alkyl (optionally substituted by a phenyl (optionally substituted)). Provided that when D is Si(CH 3) 3, then v is 0 and R 1-R 3are methyl. [Image].

Description

COSMETIC COMPOSITION CONTAINING A DIBENZOYLMETHANE DERIVATIVE AND A DITHIOLANE SILICIE COMPOUND; The present invention relates to a cosmetic composition containing the combination of at least one filter of the dibenzoylmethane derivative type and of at least one siliconized dithiolane compound of formula (I), the definition of which will be defined. below.

It also relates to a photostabilization process with respect to the radiation of at least one filter of the dibenzoylmethane derivative type with a silicon dithiolane compound of formula (I) of formula (I), the definition of which will be given below. .

The present invention also relates to the use of at least one silicon dithiolane compound of formula (I) in formula (I) in a composition comprising, in a cosmetically acceptable carrier, at least one derivative of dibenzoylmethane for the purpose of to improve the effectiveness of said composition vis-à-vis UV-A. It is known that the luminous radiations of wavelengths between 280 nm and 400 nm allow the browning of the human epidermis, and that the wavelength rays more particularly between 280 and 320 nm, known under the name UV-B, cause erythema and skin burns which can hinder the development of natural tanning. For these reasons as well as for aesthetic reasons, there is a constant demand for means of control of this natural tan to thereby control the color of the skin; it is therefore necessary to filter this UV-B radiation.

It is also known that UV-A rays of wavelengths between 320 and 400 nm, which cause browning of the skin, are likely to induce an alteration thereof, particularly in the case of sensitive skin or skin continuously exposed to solar radiation. UV-A rays cause in particular a loss of elasticity of the skin and the appearance of wrinkles leading to premature cutaneous aging. They promote the triggering of the erythematous reaction or amplify this reaction in some subjects and may even be the cause of phototoxic or photoallergic reactions. Thus, for aesthetic and cosmetic reasons such as the preservation of the natural elasticity of the skin for example, more and more people want to control the effect of UV-A on their skin. It is therefore desirable to also filter the UV-A radiation.

In order to protect the skin and the keratin materials against UV radiation, antisolar compositions comprising organic screening agents active in UV-A and active in UV-B are generally used. Most of these filters are fat soluble.

In this respect, a particularly interesting family of UV-A filters currently consists of the dibenzoylmethane derivatives, and in particular 4-tert-butyl-4'-methoxydibenzoylmethane, which in fact have a high intrinsic absorption capacity. These dibenzoylmethane derivatives, which are now products that are well known per se as active filters in UV-A, are described in particular in French patent applications FR-A-2326405 and FR-A-2440933, as well as in European Patent Application EP-A-0114607; 4-tert-butyl-4'-methoxydibenzoyl methane is also currently offered for sale under the trade name PARSOL 1789 by DSM NUTRITIONAL PRODUCTS.

Unfortunately, it turns out that the dibenzoylmethane derivatives are relatively sensitive to ultraviolet (especially UV-A) radiation, that is to say, more precisely, that they have an unfortunate tendency to degrade more or less quickly under the action of the latter. Thus, this substantial lack of photochemical stability of the dibenzoylmethane derivatives against the ultraviolet radiation to which they are inherently intended to be subjected, does not guarantee a constant protection during prolonged sun exposure, so that repeated applications at intervals of Regular and close times must be performed by the user to achieve effective protection of the skin against UV rays.

The photostabilisation of dibenzoylmethane derivatives with respect to UV radiation by amidated compounds thus constitutes, to date, a problem which has not yet been solved in a completely satisfactory manner.

Now, the Applicant has now discovered, surprisingly, that by associating with the dibenzoylmethane derivatives mentioned above a silicon dithiolane compound of formula (I) which will be defined in detail later, it was possible to to further substantially and remarkably improve the photochemical stability (or photostability) of these same dibenzoylmethane derivatives and their effectiveness in UV-A. The compositions containing such an association also lead after application to a more homogeneous distribution of the dibenzoylmethane filter. This discovery is the basis of the present invention.

Thus, according to one of the objects of the present invention, there is now proposed a composition comprising in a cosmetically acceptable support at least one UV filtering system, characterized in that it comprises: (a) at least one derivative dibenzoylmethane and (b) at least one silicon dithiolane compound of formula (I) which will be given the following definition. Another object of the invention also relates to a process for improving the chemical stability with respect to the UV radiation of at least one dibenzoylmethane derivative comprising associating with said dibenzoylmethane derivative an effective amount of at least one dithiolane compound. The present invention also relates to the use of at least one silicon dithiolane compound of formula (I) in a composition comprising, in a cosmetically acceptable carrier, at least one a derivative of dibenzoylmethane in order to improve the effectiveness of said composition vis-à-vis UV-A.

Other features, aspects and advantages of the invention will appear on reading the detailed description which follows. By "cosmetically acceptable" is meant compatible with the skin and / or its integuments, which has a pleasant color, odor and feel and which does not generate unacceptable discomfort (tingling, tightness, redness), which can divert the consumer to use this composition. Effective amount means an amount sufficient to achieve a significant and significant improvement in the photostability of the dibenzoylmethane derivative (s) in the cosmetic composition. This minimum amount of silicon dithiolane compound of formula (I), which may vary according to the nature of the support selected for the composition, can be determined without any difficulty by means of a conventional photostability measurement test, such as that given in US Pat. the examples below.

The compounds according to the present invention correspond to the following general formula (I): R 3 D 1 -C Si -R 2 YH (W) V R 1 (I) in which m represents an integer which can be 0, 1, 2 , 3, 4, 5, 6, 7, 8; X represents an oxygen, nitrogen or sulfur atom; Y is oxygen, nitrogen, NR4 or sulfur; v represents an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10; R 1, R 2, R 3 represent, independently of one another, a saturated or unsaturated C 3 -C 10 linear or branched C 1 -C 10 alkyl radical which may comprise one or more halogen atoms (for example Cl, Br, F), a phenyl radical, a benzyl radical; D denotes hydrogen, a linear C 1 -C 8 or branched C 2 -C 8 alkyl radical, saturated or unsaturated, a phenyl radical; the group Si (CH 3) 3 with the proviso that when D is Si (CH 3) 3 then v = 0 and R 1, R 2 and R 3 are methyl; W is a linear C 1 -C 8, or branched C 3 -C 8 saturated or unsaturated, or C 2 -C 8 alkylene radical, optionally substituted by a hydroxyl; R4 represents a hydrogen, a C1-C20 linear or branched C3-C20 alkyl, saturated or unsaturated, optionally substituted with an optionally substituted phenyl radical. In formula (II) above, compounds are preferred for which: m = 4; X = O; Y = OouNR4; R1 to R3 denote linear C1-C4 or branched C3-C4 alkyl may include a phenyl radical, and more particularly, methyl, ethyl, phenyl or ùCH2-Ph; R4 represents hydrogen, a saturated or unsaturated C1-C20 or branched C3-C20 linear alkyl, optionally substituted with an optionally substituted phenyl radical; v = 0.1 or 2; W is methylene -CH 2 - or ùGNON-CH 2 - when v is other than 0; D is -H or (CH3) 3.

In formula (II) above, compounds such as: m = 4; X = O; Y = OouNH; R1 to R3 denote C1-C4 alkyl and more particularly methyl; W is methylene -CH2-.

The compounds of formula (I) that are particularly preferred are chosen from the following compounds: No. Structure Chemical Name 1 ss 1 -5- (1,2-dithiolan-3-yl) pentanoate, if (trimethylsilyl) methyl o 2 ss 5- ( Α-2- (trimethylsilyl) ethyl-1,3-diisopropyl 5- (1,2-dithiolan-3-yl) pentanoate 1,2-dithiolan-3-yl) pentanoate 4- (trimethylsilyl) propyl 4-sis 5- (2- [3-hydroxy-3-yl) -2-hydroxy-3- (1-ethyl (dimethyl) silyl] methyl (2-dithiolan-3-yl) pentanoate (tri methylsilyl) propyl ~ o 6 ss 5- (1,2-dithiolan-3-yl) pentanoate; [dimethyl (phenyl) silyl] methyl No. Structure Chemical Name 7 ss 5- [1,2-dithiolan-3-yl] pentanoate [benzyl (dimethyl) silyl] methyl o 8 SS H 1-5 ( 1,2-dithiolan-3-yl) -N- [(trimethylsilyl) methyl] pentanamide o 9 SS 1 N- [bis (trimethylsilyl) methyl] -5- (1,2-N-dithiolan-3-yl) The compounds of formula (I) which are even more particularly preferred are chosen from the following compounds: ## STR2 ## , 8 and 9: The compounds of formula (I) can be obtained according to two general approaches.

The first conventionally employs a hydrosilylation reaction from the corresponding siloxane or silane derivative in which, for example, all A radicals are hydrogen atoms. This derivative is hereinafter referred to as SiH.

SiH groups may be present in the chain and / or at the ends of the chain. These SiH derivatives are well known products in the silicone industry and are generally commercially available. They are for example described in US Pat. Nos. 3,220,972, 3,679,473 and 4,340,709.

The SiH derivatives corresponding to the compounds of formulas (I) can therefore be represented by the following formula (2):

H-SiR1R2R3 (2) in which: R1, R2 and R3 have the meaning given above for formula (I),

In order to prepare the compounds of the invention of formulas (I) above, the procedure is as follows: on the SiH derivative of formulas (2), a hydrosilylation reaction is carried out in the presence of a quantity catalytically effective solution of a platinum catalyst on a dithiolane organic derivative selected from those of the following formula (53):

wherein X, Y, and m have the same meaning as in formula (I) above and L 'is one of the following two formulas (b) and (b'):

In which: Z is a linear or branched, saturated or unsaturated C 1 -C 6 alkane di-yl radical, optionally substituted by a hydroxyl radical; or C2-C8 alkyl, linear or branched, saturated or unsaturated; Y 'represents a hydrogen atom, a hydroxyl radical or a linear or branched, saturated or unsaturated C1-C8 alkyl radical; pest0ou 1.

The hydrosilylation reaction is therefore carried out according to one of the following two reactions:

= Si-H + CH2 = C> = Si-CH2-CH- (grafting on formula (b))

or

= Si-H + CH-C> Si-CH = CH- and / or = Si-C = CH2 (grafting on the formula (b '))

For example, on a lipoic derivative having an allylamide function: ## STR1 ## A second route for preparing the compounds of formula (I) consists in carrying out reactions of esterification or formation of esters, thioesters or amides from carboxylic acid or derivatives synthetically compatible with the chosen route.

These derivatives can be obtained by one of the four routes described in the following scheme taken with the skeleton as lipoic acid: ## STR1 ## ~ (W) v R1 o sùs SiùR2 sùs o ON HY sùs ss oD R3 Si ùR2 H .., (W) v R1 where Y, D, W, RI to R3 and v have the same meanings as those indicated above for the formula (I), Hal represents a halogen and more particularly chlorine and M + represents an alkali metal and more particularly sodium or potassium.

As reagents, mention may be made of hydroxymethyltrimethylsilane (RN 3219-63-4), 2- (trimethylsilyl) ethanol (RN 2916-68-9) or 3 (trimethylsilyl) propanol (RN 2917-47-7) which are commercial products.

As silane halide derivatives, there may be mentioned chloropropyltrimethylsilane (RN 2344-83-4) or chloromethyltrimethylsilane (RN 2344-80-1) sold by the company Wacker. Also suitable are the following commercial products: iodomethyltrimethylsilane (RN 4206-67-1), (chloromethyl) dimethylethylsilane (RN 3121-77-5), (chloromethyl) dimethyl-n-butylsilane (RN 3121-75 -3), (chloromethyl) dimethylpentylsilane (RN73013-59), (chloromethyl) dodecyldimethylsilane (RN 70851-47-7), (chloromethyl) triethylsilane (RN 757-34-6), 2-chloroethyltrimethylsilane ( RN 7787-87-3), Bis (trimethylsilyl) methylchloride (RN 5926-35-2), (chloromethyl) dimethylphenylsilane (RN 1833-51-8), (chloromethyl) diphenylmethylsilane (RN 18407-40 -4) and (trimethylsilylmethyl) dimethylchloromethylsilane (RN 18306-73-5).

Mention may be made of aminomethyltrimethylsilane (RN 18166-02-4) sold by Gelest and also (phenyl) (trimethylsilyl) methylamine, bis (trimethylsilyl) methylamine (RN 134340-00-4), aminopropyltrimethylsilane ( RN 18187-14-9) as well as other compounds cited by Speier JL, J. Org. Chem, 1971, 36, 21, 3120-3126 and Shina K, CAS RN 1961, 81299. Particularly preferred compounds of formula (I) can be advantageously obtained from lipoic acid. The siliceous dithiolane compounds of formula (I) are preferably present in the composition according to the invention in a content ranging from 0.1% to 40% by weight, relative to the total weight of the composition, and preferably ranging from , 1 to 30% by weight.

Among the derivatives of dibenzoylmethane, there may be mentioned, without limitation: 2-methyldibenzoylmethane, 4-methyldibenzoylmethane, 4-isopropyldibenzoylmethane, 4-tert-butyldibenzoylmethane, dimethyldibenzoylmethane, 15-2,5-dimethyldibenzoylmethane, 4,4'-diisopropyldibenzoylmethane, 4,4'-dimethoxydibenzoylmethane, 4-tert-butyl-4'-methoxydibenzoylmethane, 2-methyl-5 isopropyl-4'-methoxydibenzoylmethane, 2-methyl-5-tert-butyl-4'-methoxydibenzoylmethane, 2,4-dimethyl-4'-methoxydibenzoylmethane, 2,6-dimethyl-4-tert butyl-4'-methoxydibenzoylmethane.

Among the dibenzoylmethane derivatives mentioned above, use will in particular be made of 4-isopropyl-dibenzoylmethane, sold under the name "Eusolex 8020" by the company Merck, and having the following formula: employing 4- (tert-butyl) -4'-methoxy dibenzoylmethane or Butyl Methoxy Dibenzoylmethane, offered for sale under the trade name "PARSOL 1789" by the company DSM NUTRITIONAL PRODUCTS; this filter has the following formula: The dibenzoylmethane derivative (s) may be present in the compositions in accordance with the invention at contents which preferably vary from 0.01 to 10% by weight and more preferably from 0.1 to 6% by weight. % by weight relative to the total weight of the composition. OMe The compositions in accordance with the invention may comprise, in addition to other water-soluble or liposoluble, or otherwise insoluble UVA and / or UVB UV-screening agents in the commonly used cosmetic solvents.

Of course, those skilled in the art will take care to choose the optional additional filters and / or their amounts in such a way that the advantageous properties intrinsically attached to the compositions according to the invention are not, or not substantially, altered by the addition or additions envisaged, in particular the improvement of the photostability of the dibenzoylmethane derivative.

The complementary organic screening agents are chosen in particular from anthranilates; cinnamic derivatives; salicylic derivatives, camphor derivatives; benzophenone derivatives; R, R-diphenylacrylate derivatives; triazine derivatives; benzotriazole derivatives; benzalmalonate derivatives including those cited in US5624663; benzimidazole derivatives; imidazolines; bisbenzoazolyl derivatives as described in patents EP669323 and US 2,463,264; p-aminobenzoic acid (PABA) derivatives; methylene bis- (hydroxyphenylbenzotriazole) derivatives as described in US5,237,071, US 5,166,355, GB2303549, DE 197 26 184 and EP893119; benzoxazole derivatives as described in patent applications EP0832642, EP1027883, EP1300137 and DE10162844; filter polymers and silicone filters such as those described in particular in the application WO-93/04665; dimers derived from α-alkylstyrene such as those described in patent application DE19855649; 4,4-diarylbutadienes as described in applications EP0967200, DE19746654, DE19755649, EP-A-1008586, EP1133980 and EP133981; merocyanine derivatives such as those described in WO04006878, WO05058269 and WO06032741 and mixtures thereof.

As examples of complementary organic photoprotective agents, mention may be made of those referred to below under their INCI name: under the trade name NEO HELIOPAN E Derivatives of para-aminobenzoic acid: PABA, Ethyl PABA, Ethyl Dihydroxypropyl PABA, 40 45 Cinnamic Derivatives: Ethylhexyl Methoxycinnamate sold in particular PARSOL MCX by DSM Nutritional Products, Inc., Isopropyl Methoxycinnamate Isoamyl Methoxycinnamate sold under the name 1000 by SYMRISE, DEA Methoxycinnamate, Diisopropyl Methylcinnamate, Glyceryl Ethylhexanoate Dimethoxycinnamate Ethylhexyl Dimethyl PABA sold in particular under the name Escalol 507 by ISP, Glyceryl PABA, PEG-25 PABA sold under the name Uvinol P25 by BASF, Salicylic derivatives: Homosalate sold under the name Eusolex HMS by Rona / EM Industries, Ethylhexyl salicylate sold under the name NEO HELIOPAN OS by SYMRISE, Dipropylene glycol salicylate sold under the name DIPSAL by SCHER, TEA Salicylate, sold under the name NEO HELIOPAN TS by SYMRISE, Derivatives of 6,6-diphenylacrylate: Octocrylene sold in particular under the trade name UVINUL N539 by BASF, Etocrylene, sold in particular under the trade name UVINUL N35 by BASF,

Derivatives of benzophenone: Benzophenone-1 sold under the trade name UVINUL 400 by BASF, Benzophenone-2 sold under the trade name UVINUL D50 by BASF Benzophenone-3 or Oxybenzone, sold under the trade name UVINUL M40 by BASF, Benzophenone-4 sold under the trade name UVINUL MS40 by BASF, 25 Benzophenone-5 Benzophenone-6 sold under the trade name Helisorb 11 by Norquay Benzophenone-8 sold under the trade name Spectra-Sorb UV-24 by American Cyanamid Benzophenone-9 sold under the name commercial UVINUL DS-49 by BASF, n-hexyl benzophenone-12 2- (4-diethylamino-2-hydroxybenzoyl) benzoate sold under the trade name UVINUL A + by BASF.

Derivatives of benzylidene camphor: 3-Benzylidene camphor manufactured under the name MEXORYL SD by CHIMEX, 4-Methylbenzylidene camphor sold under the name EUSOLEX 6300 by MERCK, Benzylidene Camphor Sulfonic Acid manufactured under the name MEXORYL SL by CHIMEX, 40 Camphor Benzalkonium Methosulfate manufactured under the name MEXORYL SO by CHIMEX, Terephthalylidene Dicamphor Sulfonic Acid manufactured under the name MEXORYL SX by CHIMEX, Polyacrylamidomethyl Benzylidene Camphor manufactured under the name MEXORYL 45 SW by CHIMEX, derivatives of phenyl benzimidazole: Phenylbenzimidazole Sulfonic Acid sold in particular under the trade name EUSOLEX 232 by MERCK, Disodium Phenyl Dibenzimidazole Tetrasulfonate sold under the trade name NEO HELIOPAN AP by SYMRISE,

Derivatives of phenyl benzotriazole: Drometrizole Trisiloxane sold under the name Silatrizole by Rhodia Chimie Methylene bis-Benzotriazolyl Tetramethylbutylphenol, sold in solid form under the trade name MIXXIM BB / 100 by FAIRMOUNT CHEMICAL or in micronized form in aqueous dispersion under the trade name TINOSORB M by CIBA SPECIALTY CHEMICALS,

Triazine derivatives: 15-Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine sold under the trade name Tinosorb S by Ciba Geigy, Ethylhexyl Triazone sold in particular under the trade name UVINUL T150 by BASF, Diethylhexyl Butamido Triazone sold under the trade name UVASORB 20 HEB by SIGMA 3V, 2,4,6-tris (dineopentyl 4'-amino benzalmalonate) -s-triazine - 2,4,6-tris- (4'-amino benzalmalonate diisobutyl) -s-triazine, - 2,4bis (n-butyl 4'-aminobenzoate) -6- (aminopropyltrisiloxane) -s-triazine, 2,4bis (dineopentyl 4'-aminobenzalmalonate) -6- (n-butyl 4'-aminobenzoate) ) -s-triazine, - the symmetrical triazine filters described in US Pat. No. 6,225,467, WO2004 / 085412 (see compounds 6 and 9) or the Symetrical Triazine Derivatives IP.COM Journal, IP.COM INC. WEST HENRIETTA, NY , US (September 20, 2004) including 2,4,6-tris- (biphenyl) -1,3,5-triazines (especially 2,4,6-tris (biphenyl-4-yl-1,3) , 5-triazine e 2,4,6-tris (terphenyl) -1,3,5-triazine which is incorporated in patent applications WO06 / 035000, WO06 / 034982, WO06 / 034991, WO06 / 035007, WO2006 / 034992, WO2006 / 034,985.

Anthranilic Derivatives: Menthyl anthranilate sold under the trade name NEO HELIOPAN MA by SYMRISE,

Imidazoline derivatives: 40 Ethylhexyl Dimethoxybenzylidene Dioxoimidazoline Propionate,

Benzalmalonate Derivatives: Benzalmalonate functional polyorganosiloxane such as Polysilicone-15 sold under the trade name PARSOL SLX by DSM 45 Nutritional Products, Inc.

4,4-Diarylbutadiene derivatives: 1,1-dicarboxy (2,2'-dimethyl-propyl) -4,4-diphenylbutadiene5 Benzoxazole derivatives: 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2 -yl- (4-phenyl) imino] -6- (2-ethylhexyl) imino-1,3,5-triazine sold as Uvasorb K2A by Sigma 3V and mixtures thereof. Merocyanine Derivatives Octyl-5-N, N-diethylamino-2-phenysulfonyl-2,4-pentadienoate

The preferred organic screening agents are selected from ethylhexyl methoxycinnamate ethylhexyl salicylate, homosalate, octocrylene, phenylbenzimidazole sulfonic acid, benzophenone-3, benzophenone-4, benzophenone-5, 2- (4-diethylamino-2-hydroxybenzoyl) benzoate. hexyl. 4-Methylbenzylidene camphor, Terephthalylidene Dicamphor Sulfonic Acid, Disodium Phenyl Dibenzimidazole Tetrasulfonate, Methylene bis-Benzotriazolyl Tetramethylbutylphenol Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine Ethylhexyl triazone, Diethylhexyl Butamido Triazone, 2,4,6-tris (4'-amino benzalmalonate) dineopentyl) -s-triazine 2,4,6-tris- (4'-amino benzalmalonate diisobutyl) -s-triazine 2,4bis (n-butyl 4-aminobenzoate) -6- (aminopropyltrisiloxane) s-triazine, 2,4bis (dineopentyl 4'-aminobenzalmalonate) -6- (n-butyl 4'-aminobenzoate) -s-triazine, 2,4,6-tris (biphenyl-4-yl) 1,3,5-triazine 2,4,6-tris (terphenyl) -1,3,5-triazine Drometrizole Trisiloxane Polysilicone-15 1,1-dicarboxy (2,2'-dimethyl-propyl) -4, 4-diphenylbutadiene 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) imino] -6- (2-ethylhexyl) imino-1,3,5-triazine octyl- 5-N, N-diethylamino-2-phenysulfonyl-2,4-pentadienoate and mixtures thereof.

The complementary inorganic filters are chosen from coated or uncoated metallic oxide pigments, the average size of the primary particles of which is preferably between 5 nm and 100 nm (preferably between 10 nm and 50 nm), for example dye pigments. titanium oxide (amorphous or crystallized in rutile and / or anatase form), iron, zinc, zirconium or cerium or mixtures thereof which are all UV photoprotective agents well known per se.

The pigments may be coated or uncoated.

The coated pigments are pigments which have undergone one or more surface treatments of a chemical, electronic, mechanochemical and / or mechanical nature with compounds as described, for example, in Cosmetics & Toiletries, February 1990, Vol. 105, p. 53-64, such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surfactants, lecithins, sodium, potassium, zinc, iron or aluminum salts of fatty acids, metal alkoxides (of titanium or aluminum), polyethylene, silicones, proteins (collagen, elastin), alkanolamines, silicon oxides, metal oxides or sodium hexametaphosphate.

In a known manner, the silicones are organosilicon polymers or oligomers with a linear or cyclic, branched or crosslinked structure, of variable molecular weight, obtained by polymerization and / or polycondensation of suitably functionalized silanes, and essentially constituted by a repetition of main motifs in which the silicon atoms are connected to each other by oxygen atoms (siloxane bond), optionally substituted hydrocarbon radicals being directly bonded via a carbon atom to said silicon atoms. The term "silicones" also includes the silanes necessary for their preparation, in particular alkyl silanes.

The silicones used for coating the pigments suitable for the present invention are preferably selected from the group containing alkyl silanes, polydialkylsiloxanes, and polyalkylhydrogensiloxanes. Even more preferentially, the silicones are chosen from the group containing octyl trimethyl silane, polydimethylsiloxanes and polymethylhydrogensiloxanes. Of course, the metal oxide pigments before their treatment with silicones may have been treated with other surfactants, in particular with cerium oxide, alumina, silica, aluminum, silicon compounds, or mixtures thereof. The coated pigments are more particularly titanium oxides coated with: silica, such as the product "Sunveil" from the company IKEDA and the product "Eusolex T-AVO" from the company Merck - silica and iron oxide such as that the product "SUNVEIL F" of the company IKEDA 40, - silica and alumina such as the products "MICROTITANIUM DIOXIDE MT 500 SA" and "MICROTITANIUM DIOXIDE MT 100 SA" of the company TAYCA, "TIOVEIL" of the company TIOXIDE, and Mirasun TiW 60 from Rhodia, - alumina such as the products "TIPAQUE TTO-55 (B)" and "TIPAQUE TTO-55 45 (A)" from ISHIHARA, and "UVT 14/4 of the company KEMIRA, aluminum alumina and stearate such as the product MICROTITANIUM DIOXIDE MT 100 TV, MT 100 TX, MT 100 Z, MT-01 from the company TAYCA, the products Solaveil CT-10 W "," Solaveil CT 100 "and" Solaveil CT 200 "from the company UNIQEMA, - silica, alumina and alginic acid such as the product" MT-100 AQ "from the company TAYCA, - of aluminum alumina and laurate such as the product "MICROTITANIUM DIOXIDE MT 100 S" from the company TAYCA, iron oxide and iron stearate such as the product "MICROTITANIUM DIOXIDE MT 100 F" from the company TAYCA, zinc oxide and zinc stearate such as the product "BR351" from TAYCA, silica and alumina and treated with a silicone such as "MICROTITANIUM DIOXIDE MT 600 SAS" products, "MICROTITANIUM DIOXIDE MT 500 SAS" or "MICROTITANIUM DIOXIDE MT 100 SAS" from TAYCA, - silica, alumina, aluminum stearate and treated with a silicone such as the product "STT-30-DS" of TITAN KOGYO, - silica and treated with a silicone such as the product "UV-TITAN X 195" Kemira company, or the product SMT-100 WRS TAYCA society. of alumina and treated with a silicone such as the products "TIPAQUE TTO-55 (S)" from ISHIHARA, or "UV TITAN M 262" from KEMIRA, of triethanolamine such as the product "STT-65- S "of the company TITAN KOGYO, 20 - of stearic acid such as the product" TIPAQUE TTO-55 (C) "from the company ISHIHARA, - sodium hexametaphosphate such as the product" MICROTITANIUM DIOXIDE MT 150 W "of the company TAYCA.

Other titanium oxide pigments treated with a silicone are preferably TiO 2 treated with octyl trimethyl silane and having an average elemental particle size of between 25 and 40 nm, such as that sold under the trade name " T 805 "by the company DEGUSSA SILICES, TiO 2 treated with a polydimethylsiloxane and whose average elemental particle size is 21 nm, such as that sold under the trade name" 70250 Cardre UF TiO2SI3 "by CARDRE, anatase TiO 2 / rutile treated with a polydimethylhydrogensiloxane and whose average elementary particle size is 25 nm such as that sold under the trade name "MICRO TITANIUM DIOXIDE USP GRADE 35 HYDROPHOBIC" by the company COLOR TECHNIQUES.

The uncoated titanium oxide pigments are for example sold by the company Tayca under the trade names "MICROTITANIUM DIOXIDE MT 500 B" or "MICROTITANIUM DIOXIDE 40 MT600 B", by the company DEGUSSA under the name "P 25", by the company WACKHER under the name "transparent titanium oxide PW", by the company MIYOSHI KASEI under the name "UFTR", by the company TOMEN under the name "ITS" and by the company TIOXIDE under the name "TIOVEIL AQ". The uncoated zinc oxide pigments are, for example, those marketed under the name "Z-cote" by the company Sunsmart; those marketed under the name "Nanox" by Elementis; those marketed under the name Nanogard WCD 2025 by the company Nanophase Technologies; The coated zinc oxide pigments are, for example, those marketed under the name Z-COTE HP1 by Sunsmart (dimethicone-coated ZnO); those marketed under the name "Zinc Oxide CS-5" by the company Toshibi (ZnO coated with polymethylhydrogenosiloxane); those marketed under the name "Nanogard Zinc Oxide FN" by Nanophase Technologies (as a 40% dispersion in Finsolv TN, C12-C15 alcohol benzoate); - those sold under the name "DAITOPERSION ZN-30" and "DAITOPERSION Zn-50" by the company Daito (dispersions in cyclopolymethylsiloxane / polydimethylsiloxane oxyethylenated, containing 30% or 50% of zinc nano-oxides coated with silica and the polymethylhydrogensiloxane); Those marketed under the name "NFD Ultrafine ZnO" by the company Daikin (ZnO coated with perfluoroalkyl phosphate and a copolymer based on perfluoroalkylethyl dispersed in cyclopentasiloxane); those marketed under the name "SPD-Z1" by the company Shin-Etsu (ZnO coated with silicone-grafted acrylic polymer, dispersed in cyclodimethylsiloxane); those marketed under the name "Escalol Z100" by the company ISP (ZnO treated alumina and dispersed in the mixture methoxycinnamate ethylhexyl / copolymer PVP-hexadecene / methicone); those marketed under the name "Fuji ZnO-SMS-10" by the company Fuji Pigment (ZnO coated with silica and polymethylsilsesquioxane); those marketed under the name "Nanox Gel TN" by Elementis (ZnO dispersed at 55% in C12-C15 alcohols benzoate with hydroxystearic acid polycondensate).

The uncoated cerium oxide pigments are sold for example under the name "COLLOIDAL CERIUM OXIDE" by the company RHONE POULENC. Uncoated iron oxide nanopigments are for example sold by ARNAUD under the names "NANOGARD WCD 2002 (FE 45B)", "NANOGARD IRON FE 45 BL AQ", "NANOGARD FE 45R AQ," NANOGARD WCD 2006 (FE 45R) ", or by the company MITSUBISHI under the name" TY-220 ".

The coated iron oxide pigments are for example sold by the company ARNAUD under the names "NANOGARD WCD 2008 (FE 45B FN)", "NANOGARD WCD 2009 (FE 45B 556)", "NANOGARD FE 45 BL 345", "NANOGARD FE 45 BL", or by the company BASF under the name "OXIDE OF CLEAR IRON".

Mention may also be made of mixtures of metal oxides, in particular of titanium dioxide and cerium dioxide, of which the titanium dioxide / cerium-coated cerium alloy mixture is coated by silica, sold by the company IKEDA under the name "SUNVEIL" A ", as well as the mixture of titanium dioxide and zinc dioxide coated with alumina, silica and silicone such as the product" M 261 "sold by the company KEMIRA or coated with alumina, silica and glycerin such as the product "M 211" sold by KEMIRA.

The additional UV filters are generally present in the compositions according to the invention in proportions ranging from 0.01% to 20% by weight relative to the total weight of the composition, and preferably ranging from 0.1% to 10% by weight relative to the total weight of the composition. relative to the total weight of the composition.

The aqueous compositions in accordance with the present invention may further comprise conventional cosmetic adjuvants, chosen in particular from fatty substances, organic solvents, ionic or nonionic, hydrophilic or lipophilic thickeners, softeners, humectants, opacifiers and stabilizers. , emollients, silicones, anti-foam agents, perfumes, preservatives, anionic, cationic, non-ionic, zwitterionic or amphoteric surfactants, actives, fillers, polymers, propellants, alkalinizing agents or acidifying agents or any other ingredient usually used in the cosmetic and / or dermatological field.

The fatty substances may consist of an oil or a wax other than the apolar waxes as defined above or their mixtures. By oil is meant a liquid compound at room temperature. By wax is meant a compound that is solid or substantially solid at room temperature and whose melting point is generally greater than 35 ° C.

As oils, there may be mentioned mineral oils (paraffin); vegetable (sweet almond oil, macadamia oil, blackcurrant seed oil, jojoba oil); synthetic such as perhydrosqualene, alcohols, fatty amides (such as isopropyl lauroyl sarcosinate sold under the name Eldew SL-205 by the company Ajinomoto), fatty acids or esters such as benzoate of C12 alcohols. C15 sold under the trade name Finsolv TN or Witconol TN by the company WITCO, 2-ethylphenyl benzoate as the commercial product sold under the name X-TEND 226 by the company ISP, octyl palmitate, isopropyl lanolate triglycerides, including those of capric / caprylic acids, dicaprylyl carbonate sold under the name Cetiol CC by Cognis), oxyethylenated or oxypropylenated esters and fatty ethers; silicone oils (cyclomethicone, polydimethylsiloxane or PDMS) or fluorinated oils, polyalkylenes, trialkyl trimellitates such as tridecyl trimellitate.

As waxy compounds, mention may be made of carnauba wax, beeswax, hydrogenated castor oil, polyethylene waxes and polymethylene waxes, such as that sold under the name Cirebelle 303 by the company SASOL.

Among the organic solvents, lower alcohols and polyols may be mentioned. These can be selected from glycols and glycol ethers such as ethylene glycol, propylene glycol, butylene glycol, dipropylene glycol or diethylene glycol.

As hydrophilic thickeners, mention may be made of carboxyvinyl polymers such as Carbopols (Carbomers) and Pemulen (acrylate / C10-C30-alkylacrylate copolymer); polyacrylamides, for example crosslinked copolymers sold under the names Sepigel 305 (CTFA name: polyacrylamide / C13-14 isoparaffin / Laureth 7) or Simulgel 600 (CTFA name: acrylamide / sodium acryloyldimethyltaurate copolymer / isohexadecane / polysorbate 80) by the company Seppic ; polymers and copolymers of 2-acrylamido-2-methylpropanesulphonic acid, optionally cross-linked and / or neutralized, such as poly (2-acrylamido-2-methylpropanesulphonic acid) marketed by Hoechst under the trade name Hostacerin AMPS (CTFA name ammonium polyacryloyldimethyl taurate or SIMULGEL 800 sold by the company SEPPIC (CTFA name: sodium polyacryolyldimethyl taurate / polysorbate 80 / sorbitan oleate); copolymers of 2-acrylamido-2-methylpropane sulfonic acid and hydroxyethyl acrylate such as SIMULGEL NS and SEPINOV EMT 10 sold by the company SEPPIC, cellulose derivatives such as hydroxyethylcellulose, polysaccharides and in particular gums such as Xanthan gum, and mixtures thereof.

As lipophilic thickeners, mention may be made of synthetic polymers such as poly C 10 -C 30 alkyl acrylates sold under the name INTELIMER IPA 13-1 and INTELIMER IPA 13-6 by the company Landec, or modified clays such as hectorite and its derivatives, such as the products marketed under the name of Bentone. Of course, those skilled in the art will take care to choose the optional additional compound or compounds mentioned above and / or their amounts in such a way that the advantageous properties intrinsically attached to the compositions in accordance with the invention are not, or substantially not, altered by the envisaged additions or additions, especially the improvement of the photostability of the dibenzoylmethane derivative.

The compositions according to the invention can be prepared according to the techniques well known to those skilled in the art. They may be in particular in the form of an emulsion, simple or complex (O / W, W / O, O / W / H or W / O / W) such as cream, milk or gel. cream; in the form of an aqueous gel; in the form of a lotion. They may optionally be packaged in aerosol and be in the form of foam or spray.

Preferably, the compositions according to the invention are in the form of an oil-in-water or water-in-oil emulsion.

The emulsions generally contain at least one emulsifier chosen from amphoteric, anionic, cationic or nonionic emulsifiers, used alone or as a mixture. The emulsifiers are suitably selected according to the emulsion to be obtained (W / O or O / W). The emulsions may also contain other types of stabilizers, for example fillers, gelling or thickening polymers.

As emulsifying surfactants that may be used for the preparation of W / O emulsions, mention may be made, for example, of alkyl esters or ethers of sorbitan, of glycerol or of sugars; silicone surfactants such as dimethicone copolyols such as the mixture of cyclomethicone and dimethicone copolyol, sold under the name DC 5225 C by Dow Corning, and alkyl dimethicone copolyols such as Laurylmethicone copolyol sold under the name Dow Corning 5200 Formulation Aid "by Dow Corning; cetyl dimethicone copolyol such as the product sold under the name Abil EM 90R by the company Goldschmidt and the mixture of cetyl dimethicone copolyol, polyglycerol isostearate (4 moles) and hexyl laurate sold under the name ABIL WE 09 by the company Goldschmidt. One or more coemulsifiers may also be added, which advantageously may be selected from the group consisting of alkylated polyol esters.

As alkylated esters of polyol, mention may in particular be made of polyethylene glycol esters such as PEG-30 dipolyhydroxystearate, such as the product sold under the name Arlacel P135 by the company ICI; Examples of glycerol and / or sorbitan esters that may be mentioned are polyglycerol isostearate, such as the product sold under the name Isolan GI 34 by the company Goldschmidt; sorbitan isostearate, such as the product sold under the name Arlacel 987 by the company ICI; sorbitan isostearate and glycerol, such as the product sold under the name Arlacel 986 by the company ICI, and mixtures thereof.

Examples of O / W emulsions which may be mentioned as emulsifiers are nonionic emulsifiers such as oxyalkylenated (more particularly polyoxyethylenated) fatty acid esters of glycerol; oxyalkylenated fatty acid and sorbitan esters; oxyalkylenated fatty acid esters (oxyethylenated and / or oxypropylenated) such as PEG-100 Stearate / Glyceryl Stearate sold, for example, by the company ICI under the name Arlacel 165; oxyalkylenated fatty alcohol ethers (oxyethylenated and / or oxypropylenated); sugar esters such as sucrose stearate; fatty alcohol and sugar ethers, especially alkylpolyglucosides (APG) such as decylglucoside and laurylglucoside sold for example by Henkel under the respective names Plantaren 2000 and Plantaren 1200, cetostearylglucoside optionally in admixture with alcohol cetostearyl, marketed for example under the name Montanov 68 by the company Seppic, under the name Tegocare CG90 by the company Goldschmidt and under the name Emulgade KE3302 by Henkel, as well as arachidyl glucoside, for example in the form of the mixture of arachidic and behenic alcohols and arachidylglucoside sold under the name Montanov 202 by the company Seppic. According to a particular embodiment of the invention, the mixture of the alkylpolyglucoside as defined above with the corresponding fatty alcohol may be in the form of a self-emulsifying composition, as described for example in the document WO -A-92/06778.

Among the other emulsion stabilizers, the polymers of isophthalic acid or sulfoisophthalic acid, and in particular the phthalate / sulfoisophthalate / glycol copolymers, for example the diethylene glycol / phthalate / isophthalate / 1,4 copolymer, will be used more particularly. cyclohexane dimethanol (INCI name: Polyester-5) sold under the names "Eastman AQ polymer" (AQ35S, AQ38S, AQ55S, AQ48 Ultra) by the company Eastman Chemical.

In the case of an emulsion, the aqueous phase thereof may comprise a nonionic vesicular dispersion prepared according to known methods (Bangham, Standish and Watkins, J. Mol Biol 13, 238 (1965)). FR 2 315 991 and FR 2 416 008).

The compositions according to the invention find their application in a large number of treatments, in particular cosmetics, of the skin, lips and hair, including the scalp, in particular for the protection and / or care of the skin, lips and / or hair, and / or for makeup of the skin and / or lips.

Another object of the present invention is constituted by the use of the compositions according to the invention as defined above for the manufacture of products for the cosmetic treatment of the skin, lips, nails, hair, eyelashes, eyebrows and / or scalp, including skincare products, sunscreen products and make-up products.

The cosmetic compositions according to the invention may for example be used as a makeup product.

The cosmetic compositions according to the invention may for example be used as a skincare and / or sun protection product for the face and / or the body of liquid to semi-liquid consistency, such as milks, more or less unctuous creams, gel-creams, pasta. They may optionally be packaged in aerosol and be in the form of foam or spray.

The compositions according to the invention in the form of vaporizable fluid lotions according to the invention are applied to the skin or the hair in the form of fine particles by means of pressurizing devices. The devices according to the invention are well known to those skilled in the art and include non-aerosol pumps or "atomizers", aerosol containers comprising a propellant and aerosol pumps using compressed air as a propellant. These are described in US Pat. Nos. 4,077,441 and 4,850,517 (which forms an integral part of the content of the description).

The aerosol-conditioned compositions in accordance with the invention generally contain conventional propellants such as, for example, hydrofluorinated compounds, dichlorodifluoromethane, difluoroethane, dimethyl ether, isobutane, n-butane, propane and trichlorofluoromethane. They are present preferably in amounts ranging from 15 to 50% by weight relative to the total weight of the composition.

The compositions according to the invention may also comprise, in addition, additional cosmetic and dermatological active ingredients. The additional active agents may in particular be chosen from moisturizing agents, desquamating agents, barrier-improving agents, depigmenting agents and antioxidants. dermodecontracting agents, anti-glycation agents, agents stimulating the synthesis of dermal and / or epidermal macromolecules and / or preventing their degradation, agents stimulating the proliferation of fibroblasts or keratinocytes and / or the differentiation of keratinocytes, the promoting agents maturation of the horny envelope, inhibitors of NO-synthases, peripheral benzodiazepine receptor antagonists (PBR), agents increasing the activity of the sebaceous gland, agents stimulating the energy metabolism of cells, tensing agents , liporestructuring agents, agents These are slimming agents, skin microcirculation agents, soothing and / or anti-irritant agents, sebum regulators or anti-seborrhoeic agents, astringent agents, healing agents, anti-inflammatory agents, and anti-acne agents.

The skilled person will choose the active agent (s) depending on the desired effect on the skin, hair, eyelashes, eyebrows, nails.

For the care and / or makeup of aged skin, it will preferably choose at least one active agent chosen from hydrating agents, desquamating agents, barrier-improving agents, depigmenting agents, antioxidants, dermodecontracting agents, anti-glycation agents, agents stimulating the synthesis of dermal and / or epidermal macromolecules and / or preventing their degradation, agents stimulating proliferation of fibroblasts or keratinocytes and / or differentiation of keratinocytes, agents promoting the maturation of horny envelope, NO-synthase inhibitors, peripheral benzodiazepine receptor (PBR) antagonists, sebaceous gland activity enhancing agents, cell energy stimulating agents, liporestructuring agents, and lipostructuring agents. agents promoting cutaneous microcirculation for the eye contour.

The composition may furthermore comprise at least one ingredient such as fillers with a blooming effect or agents promoting the natural coloration of the skin, intended to complete the biological effect of these active ingredients or provide an immediate visual anti-aging effect.

For the care and / or makeup of oily skin, those skilled in the art will preferably choose at least one active agent selected from desquamating agents, sebo-regulating agents or anti-seborrhoeic agents, astringent agents.

The composition may also comprise at least one additional ingredient intended to complete the biological effect of these active ingredients or to provide an immediate visual effect; mention may be made in particular of matting agents, blooming fillers, fluorescent agents, agents promoting the naturally rosy coloration of the skin and abrasive or exfoliating fillers.

1. Moisturizing or humectant agents As humectants or moisturizers, there may be mentioned in particular glycerol and its derivatives, urea and its derivatives including Hydrovance marketed by National Starch, lactic acid, hyaluronic acid, AHA, BHA, sodium pidolate, xylitol, serine, sodium lactate, ectoin and its derivatives, chitosan and its derivatives, collagen, plankton, imperata cylindra extract marketed under the name Moist 24 by the company Sederma, homopolymers of acrylic acid such as Lipidure-HM from NOF corporation, beta-glucan and in particular sodium carboxymethyl beta-glucan from Mibelle-AG-Biochemistry; a mixture of passionflower, apricot, corn, and rice bran oils marketed by Nestlé under the name NutraLipids. ; a C-glycoside derivative such as those described in patent application WO 02/051828 and in particular CRD-xylopyranoside-2-hydroxypropane in the form of a solution containing 30% by weight of active material in a water / propylene glycol mixture (60/40% by weight) such as the product manufactured by CHIMEX under the trade name MEXORYL SBB; a muscat rose oil marketed by Nestlé; an extract of microalga Prophyridium cruentum enriched in zinc marketed by Vincience under the name Algualane Zinc. ; spheres of collagen and chondroitin sulfate of marine origin (Ateocollagen) marketed by Engelhard Lyon under the name marine filling spheres; spheres of hyaluronic acid such as those marketed by Engelhard Lyon; and arginine.

Preferably, a moisturizing agent chosen from urea and its derivatives, in particular Hydrovance marketed by National Starch, hyaluronic acid, AHAs, BHAs, homopolymers of acrylic acid, such as NOF Lipidure-HM, will be used. corporation, beta-glucan and in particular sodium carboxymethyl beta-glucan from Mibelle-AG-Biochemistry; a blend of passionflower, apricot, corn, and rice bran oils marketed by Nestlé under the name NutraLipids; a C-glycoside derivative such as those described in patent application WO 02/051828 and in particular CRD-xylopyranoside-2-hydroxypropane in the form of a solution containing 30% by weight of active material in a water / propylene mixture glycol (60/40% by weight) such as the product manufactured by CHIMEX under the trade name MEXORYL SBB; a muscat rose oil marketed by Nestlé; an extract of microalga Prophyridium cruentum enriched in zinc marketed by Vincience under the name Algualane Zinc. ; spheres of collagen and chondroitin sulfate of marine origin (Ateocollagen) marketed by the company Engelhard Lyon under the name spheres 40 of marine filling; spheres of hyaluronic acid such as those marketed by Engelhard Lyon; and arginine.

2. desquamating agents

By "desquamating agent" is meant any compound capable of acting: either directly on desquamation by promoting exfoliation, such as R-hydroxyacids (BHA), in particular salicylic acid and its derivatives (of which 5-n-octanoyl 5-salicylic acid otherwise known as capryloyl salicylic acid (INCI name 5o); α-hydroxy acids (AHA), such as glycolic, citric, lactic, tartaric, malic or mandelic acids; 8-hexadecene-1,16-dicarboxylic acid or 9-octadecene dioic acid; urea and its derivatives; gentisic acid and its derivatives; oligofucoses; cinnamic acid; Saphora japonica extract; resveratrol and certain jasmonic acid derivatives; or on enzymes involved in desquamation or degradation of corneodesmosomes, glycosidases, stratum corneum chymotryptic enzyme (SCCE) or even other proteases (trypsin, chymotrypsin-like). Mention may be made of aminosulfonic compounds and in particular 4- (2-hydroxyethyl) piperazine-1-propanesulfonic acid (HEPES); 2-oxothiazolidine-4-carboxylic acid (procysteine) and its derivatives; glycine-type alpha amino acid derivatives (as described in EP-0 852 949, as well as the sodium methyl glycine diacetate marketed by BASF under the trade name TRILON M); honey ; sugar derivatives such as O-octanoyl-6-D-maltose and N-acetyl glucosamine.

Other desquamating agents that may be used in the composition according to the invention include: oligofructoses, EDTA and its derivatives, laminaria extract, o-linoleyl-6D-glucose, (3-hydroxy-acid), 2pentylcyclopentyl) acetic acid, glycerol trilactate, O-octanyl-6'-D-maltose, S carboxymethyl cysteine, silicon salicylate derivatives such as those described in patent EP 0 796 861, oligofucase such as those described in US Pat. EP 0 218 200, 5-acyl salicylic acid salts, active agents having effects on transglutaminase as in EP 0 899 330, ficus opuntia indica flower extract such as Exfolactive de Silab 8-hexadecene 1,16-dicarboxylic acid, glucose and vitamin F esters, and mixtures thereof. Preferred desquamating agents include beta-hydroxy acids, such as n-octanoyl-5-salicylic acid; urea; glycolic, citric, lactic, tartaric, malic or mandelic acids; 4- (2-hydroxyethyl) piperazine-1-propanesulfonic acid (HEPES); Saphora japonica extract; honey ; N-acetyl glucosamine; sodium methyl glycine diacetate, and mixtures thereof.

Even more preferentially, it will be used in the compositions of the invention an edsquamant agent chosen from n-octanoyl-5-salicylic acid; urea; 4- (2-hydroxyethyl) piperazine-1-propanesulfonic acid (HEPES); 40 Saphora japonica extract; honey ; N-acetyl glucosamine; sodium methyl glycine diacetate, and mixtures thereof.

3. Agents improving the barrier function

As agents improving the barrier function, mention may in particular be made of arginine, serine, an extract of Thermus thermophilus such as Sederma vénucéane, a wild yam rhizome extract (dioscorea villosa) such as Actigen Y d. Active Organics, plankton extracts such as Secma's omega plankton, yeast extracts such as Coletica's Relipidium, chestnut extract such as Silab's Recoverin, a cedar bud extract such as Gatuline Zen from Gattefossé, sphingosines such as salicyloyl sphingosine sold under the name Phytosphingosine SLC by the company Degussa, a mixture of xylitol, xylityl polyglycoside and xylitan such as Seppic Aquaxyl, solanaceous extracts such as Lipidessence of Coletica; unsaturated omega 3 oils such as rosebud oil and mixtures thereof. It is also possible to mention ceramides or derivatives, in particular ceramides of type 2 (such as N-oleoyldihydrosphingosine), type 3 (such as stearoyl-4-hydroxysphinganine in INCI name) and type 5 (such as N-oleoyldihydrosphingosine). 2-hydroxypalmitoyldihydrosphingosine, INCI name: hydroxypalmytoyl sphinganine), sphingoid-based compounds, glycosphingolipids, phospholipids, cholesterol and its derivatives, phytosterols, essential fatty acids, diacylglycerol, 4-chromanone and derivatives thereof. chromone vaseline, lanolin, shea butter, cocoa butter, lanolin, PCA salts.

Preferred agents having a restructuring effect of the cutaneous barrier include Thermus thermophilus extract, wild yam rhizome extract (dioscorea villosa), yeast extract, chestnut extract, cedar bud extract. arginine, serine, and especially ceramides of type 3 and 5; and their mixtures.

Preferably, serine, arginine or a mixture thereof will be used. 4. Depigmenting agents

As depigmenting agents, there may be mentioned in particular vitamin C and its derivatives and in particular the vit CG, CP and 3-O ethyl vitamin C, alpha and beta arbutin, ferulic acid, lucinol and its derivatives, the kojic acid, resorcinol and its derivatives, tranexamic acid and its derivatives, gentisic acid, homogentisate, methyl gentisate or homogentisate, dioic acid, D calcium panthein sulfonate, lipoic acid , ellagic acid, vitamin B3, linoleic acid and its derivatives, ceramides and their homologs, plant derivatives such as chamomile, bearberry, the family of aloe (vera, ferox, bardensis), of mulberry of skullcap; a kiwi fruit water (Actinidia chinensis) marketed by Gattefosse, an extract of Paeonia suffructicosa root such as that marketed by the company Ichimaru Pharcos under the name Botanpi Liquid B, a brown sugar extract (Saccharum officinarum), such as extract melasse marketed by the company Taiyo 40 Kagaku under the name Molasses Liquid, without this list being exhaustive.

As preferred depigmenting agents, use will be made of vitamin C and its derivatives and in particular the vit CG, CP and 3-O ethyl vitamin C, alpha and beta arbutin, ferulic acid, kojic acid, resorcinol and its derivatives, D calcium panthetine sulfonate, lipoic acid, ellagic acid, vitamin B3, a water of kiwi fruit (Actinidia chinensis) marketed by Gattefosse, a root extract of Paeonia suffructicosa such as that marketed by the Ichimaru Pharcos company under the name Botanpi Liquid B. 50. Antioxidants

There may be mentioned in particular tocopherol and its esters, in particular tocopherol acetate; ascorbic acid and its derivatives, in particular ascorbyl magnesium phosphate and ascorbyl glucoside; ferulic acid; serine; ellagic acid, phloretin, polyphenols, tannins, tannic acid, epoigallocathechins and natural extracts containing them, anthocyanins, rosemary extracts, extracts of olive leaves such as those of the company Silab , green tea extracts, resveratrol and its derivatives, ergothineine, N-acetylcysteine, a brown algae extract pelvetia canaliculata such as Secma's Pelvetiane, chlorogenic acid, biotin, chelants, such as BHT, BHA, N, N'-bis (3,4,5-trimethoxybenzyl) ethylenediamine and its salts; idebenone, plant extracts such as Pronalen Bioprotect TM from Provital; coenzyme Q10, bioflavonoids, SOD, phytantriol, lignans, melatonin, pidolates, glutathione, caprylyl glycol, phloretin, TotarolTM or Podocarpus totara extract containing totarol (totara-8, 11 , 13-trienol or 2-phenenanthrenol, 4b, 5, 6, 7, 8, 8a, 9, 10-octahydro-4b, 8,8-trimethyl-1 (1-methylethyl) - a jasmine extract such as that marketed by SILAB under the name Helisun, hesperitin laurate 20 such as Flavagrum PEG from Engelhard Lyon, an extract of Paeonia suffructicosa root such as that marketed by Ichimaru Pharcos under the name Botanpi Liquid B; lychee such as lychee pericarp extract marketed by Cognis under the name Litchiderm LS 9704, a pomegranate fruit extract (Punica Granatum), such as the product marketed by Draco Natural products.

Other anti-aging agents include DHEA and its derivatives, boswellic acid, rosemary extracts, carotenoids (B carotene, zeaxanthin, lutein), cysteic acid, copper derivatives, jasmonic acid

As preferred antioxidant, ferulic acid will be used in particular; serine; phloretin, pomegranate extract, biotin, chelants, such as BHT, BHA, N, N'-bis (3,4,5-trimethoxybenzyl) ethylenediamine and its salts, caprylyl glycol, phloretine TotarolTM, a jasmine extract such as that marketed by SILAB under the name Helisun; hesperitin laurate such as Flavagrum PEG from Engelhard Lyon; an extract of Paeonia suffructicosa root such as that marketed by the company Ichimaru Pharcos under the name Botanpi Liquid B. 40 6. Dermorelaxing or dermodecontracting agents

Mention may be made, for example, of manganese gluconate and other salts, adenosine, alverine citrate and its salts, glycine, an Iris pallida extract, a hexapeptide (Argériline R from Lipotec) or sapogenins such as the Wild yam and the carbonyl amines described in application EP1484052. As examples of sapogenins, mention may be made of those described in the patent application WO02 / 47650, in particular Wild yam, diosgenin extracted in particular from Dioscorea opposita or any extract which naturally closes or after treatment, one or more sapogenins (wild yam rhizome). agave leaf 24 which contains hecogenin and tigogenin, extracted from liliaceous and more particularly Yacca or smilax containing smilageine and sarsapogenin, or sarsaparilla root) or Actigen Y from Actives Organics ; or ginger.

DMAE (dimethyl MEA), extracts of sea fennel, Montpellier rockrose, helicryse, anise, Para cress, an Acmella Oleracea extract such as Gatuline expression of Gattefossé may also be mentioned.

Preferred dermorelaxing agents are adenosine, manganese gluconate, wild yam, sea fennel, glycine and alverine.

7. Anti-qlycation agents

By anti-glycation agent is meant a compound that prevents and / or decreases the glycation of skin proteins, particularly dermal proteins, such as collagen. As anti-glycation agents, mention may in particular be made of plant extracts of the family Ericaceae, such as an extract of blueberry (Vaccinium angusfifollium, Vaccinium myrtillus), for example that sold under the name BLUEBERRY HERBASOL EXTRACT PG by the company COSMETOCHEM , ergothioneine and its derivatives, hydroxystilbenes and their derivatives, such as resveratrol and 3,3 ', 5,5'-tetrahydroxystilbene (these anti-glycation agents are described in applications FR 2 802 425, FR 2 810 548, FR 2 796 278 and FR 2 802 420, respectively), dihydroxystilbenes and their derivatives, arginine and lysine polypeptides, such as the product sold under the name Amadorineo by Solabia, carcinine hydrochloride (marketed by Exsymol under the name ALISTIN), an extract of Helianthus annuus such as Silab's Antiglyskin, wine extracts such as white wine powder extract on maltodextrin support sold under denomination dehydrated white wine 2F by Givaudan, thioctic acid (or alpha lipoic acid), a mixture of bearberry extract and marine glycogen such as Aglycal LS 8777 from Laboratoires Sériobiologiques, a black tea extract such as Sederma Kombuchka and their mixtures.

Preferred anti-glycation agents include blueberry extracts (Vaccinium myrtillus) and black tea extract.

8. Agents stimulating the synthesis of dermal and / or epidermal macromolecules and / or preventing their de-grading: Among the active agents stimulating the macromolecules of the dermis or preventing their degradation, mention may be made of those which act:

or on the synthesis of collagen, such as extracts of Centella asiatica, 45 asiaticosides and derivatives; ascorbic acid or vitamin C and its derivatives; synthetic peptides such as iamin, the biopeptide CL or palmitoyloligopeptide marketed by SEDERMA; peptides extracted from plants, such as the soy hydrolyzate marketed by the company Coletica under the trade name Phytokine; rice peptides such as Nutripeptide from SILAB, methylsilanol mannuronate such as Algisium C marketed by Exsymol; plant hormones such as auxins and lignans; folic acid; and an extract of Medicago sativa (alfafa) such as that marketed by SILBA under the name Vitanol; a peptide extract of hazelnut such as that marketed by Solabia under the name Nuteline C; and arginine.

or on the inhibition of the degradation of collagen, in particular agents acting on the inhibition of metalloproteinases (MMP) such as more particularly MMP 1, 2, 3, 9. There may be mentioned: retinoids and derivatives, extracts of medicago sativa such as Vitanol of Silab, an extract of aphanizomenon flos-aquae (cyanophyceae) sold under the name Lanablue by Atrium Biotechnologies, oligopeptides and lipopeptides, lipoamino acids malt extract marketed by the company COLETICA under the trade name Collalift; bilberry or rosemary extracts; lycopene; isoflavones, their derivatives or plant extracts containing them, in particular soy extracts (marketed for example by the company Ichimaru PHARCOS under the trade name Flavosterone SB), red clover, flax, kakkon; an extract of lychee such as the lychee pericarp extract marketed by Cognis under the name Litchiderm LS 9704; the dipalmitol HYDROXYPROLINE sold by Seppic under the name SEPILIFT DPHP: Baccharis genistelloide or Baccharine marketed by SILAB, an extract of moringa such as Arganyl LS 9781 from Cognis; the sage extract described in application FR-A-2812544 of the labiate family (salvia officinalis Flacksmann), the Rhododendron extract, the blueberry extract, a vaccineium myrtillus extract such as those described in US Pat. application FR-A-2814950.

or on the synthesis of molecules belonging to the family of elastins (elastin and fibrillin), such as: retinol and derivatives, in particular retinol palmitate; the extract of Saccharomyces Cerivisiae sold by the company LSN under the trade name Cytovitin; and the algae extract Macrocystis pyrifera marketed by SECMA under the trade name Kelpadelie; a peptide extract of hazelnut such as that marketed by Solabia under the name Nuteline C.

or on the inhibition of the degradation of elastin, such as the peptide extract of seeds of Pisum sativum sold by the company LSN under the trade name Parelastyl; heparinoids; and the N-acylaminoamide compounds disclosed in WO 01/94381 such as {2- [acetyl- (3-trifluoromethyl-phenyl) -amino] -3-methyl-butyrylamino} -acetic acid, otherwise known as N- [ N-acetyl, N '- (3-trifluoromethyl) phenyl valyl] glycine or N-acetyl-N- [3- (trifluoromethyl) phenyl] valyl-glycine or acetyl trifluoromethyl phenyl valylglycine, or an ester thereof with an alcohol in C1-C6. ; an extract of 45 rice peptides such as Pentapharm's Colhibin, or an extract of Phyllanthus emblica such as Emblica de Rona.

or on the synthesis of glycosaminoglycans, such as the product of fermentation of milk with Lactobacillus vulgaris, sold by BROOKS under the trade name Biomin yogourth; the extract of the brown alga Padina pavonica marketed by the company Alban Müller under the trade name HSP3; the Saccharomyces cerevisiae extract available in particular from the company SILAB under the trade name Firmalift or from the company LSN under the trade name Cytovitin. ; an extract of Laminaria ochroleuca such as Laminaïne from Secma; the essence of Lucas Meyer's Mamaku, a watercress extract (Odraline de Silab).

io - on the synthesis of fibronectin, such as Salina zooplankton extract marketed by Seporga under the trade name GP4G; yeast extract available in particular from ALBAN MÜLLER under the trademark Drieline; and the palmitoyl pentapeptide marketed by SEDERMA under the trade name Matrixil.

Among the active agents stimulating epidermal macromolecules, such as fillagrin and keratins, mention may in particular be made of the lupine extract marketed by SILAB under the trademark Structurine; the extract of beech buds Fagus sylvatica marketed by Gattefosse under the trade name Gatuline RC; and Salina zooplankton extract marketed by the company SEPORGA under the trade name GP4G; Copper tripeptide from PROCYTE; ; a peptide extract of Voandzeia substerranea such as that marketed by Laboratoires Sérobiologiques under the trade name Filladyn LS 9397.

It is preferable to use an active agent stimulating the synthesis of dermal and / or epidermal macromolecules and / or preventing their degradation, chosen from glycosaminoglycan synthesis stimulating agents, elastin degradation inhibiting agents, agents stimulating the synthesis of fibronectin, agents stimulating the synthesis of epidermal macromolecules, and mixtures thereof. Even more preferentially, use will be made of a glycosaminoglycan synthesis stimulating active ingredient selected from a brown algae extract Padina pavonica, an extract of Saccharomyces cerevisiae, an extract of Laminaria ochroleuca, the essence of Mamaku, a cress extract and mixtures thereof. . As preferred active agents stimulating the synthesis of dermal and / or epidermal macromolecules and / or preventing their degradation, mention may be made of: synthetic peptides such as amin, the biopeptide CL or palmitoyloligopeptide marketed by SEDERMA; peptides 45 extracted from plants, such as the soy hydrolyzate marketed by the company Coletica under the trade name Phytokine; rice peptides such as Nutripeptide from SILAB, methylsilanol mannuronate such as Algisium C marketed by Exsymol; folic acid; an extract of Medicago sativa (alfafa) such as the product marketed by SILBA under the name Vitanol; a peptide extract of hazelnut such as that marketed by Solabia under the name Nuteline C; arginine; . an extract of aphanizomenon flos-aquae (cyanophyceae) sold under the name Lanablue by Atrium Biotechnologies, the malt extract marketed by the company Coletica under the trade name Collalift lycopene; an extract of lychee; an extract of moringa such as Arganyl LS 9781 from Cognis; an extract of vaccinium myrtillus such as those described in application FR-A-2814950; retinol and derivatives, in particular retinol palmitate; the Saccharomyces Cerivisiae extract sold by the company LSN under the trade name Cytovitin; a peptide extract of hazelnut such as that marketed by Solabia under the name Nuteline C; {2- [acetyl- (3-trifluoromethylphenyl) -amino] -3-methyl-butyrylamino} acetic acid, otherwise known as N- [N-acetyl, N '- (3-trifluoromethyl) phenyl valyl] glycine or N- acetyl-N- [3- (trifluoromethyl) phenyl] valyl-glycine or acetyl trifluoromethyl phenyl valylglycine, or an ester thereof with a C1-C6 alcohol. ; an extract of rice peptides such as Pentapharm's Colhibin, or an extract of Phyllanthus emblica such as Rona Emblica; the extract of the brown alga Padina pavonica marketed by the company Alban Müller under the trade name HSP3; The Saccharomyces cerevisiae extract available in particular from the company Silab under the trade name Firmalift or from the company LSN under the trade name Cytovitin. ; an extract of Laminaria ochroleuca such as Lamina'ine from Secma; the Mamaku essence of Lucas Meyer, the lupine extract marketed by SILAB under the trademark Structurine; the extract of beech buds Fagus sylvatica marketed by Gattefosse under the trade name Gatuline RC.

9. Proteins stimulating proliferation of fibroblasts or keratinocytes and / or differentiation of keratinocytes

The agents stimulating the proliferation of fibroblasts that may be used in the composition according to the invention may for example be chosen from plant proteins or polypeptides, extracted especially from soybean (for example, a soybean extract sold by the company LSN under the name Eleseryl SH- VEG 8 or marketed by SILAB under the trade name Raffermine); an extract of hydrolysed soy protein such as RIDULISSE SILAB; and plant hormones such as giberrellins and cytokinins; a peptide extract of hazelnut such as that sold by the company Solabia under the name Nuteline C.

Preferably, an agent promoting proliferation and / or differentiation of keratinocytes will be used.

The agents stimulating the proliferation of keratinocytes, which can be used in the composition according to the invention, comprise in particular adenosine; phloroglucinol, hydrangea macrophylla leaf extract such as Ichimaru Pharcos' Amacha liquid E, a yeast extract such as CLR Stimoderm; Larrea divaricata extract such as Sederma's Capislow, papaya extract, olive leaf and lemon extracts such as Vincient Xyline, hydrangea macrophylla leaf extract such as Amacha liquid E Ichimaru Pharcos, retinol and its esters including retinyl palmitate, phloroglucinol, walnut cake extracts marketed by Gattefosse and extracts of solanum tuberosum such as Dermolectin marketed by Sederma.

Among the agents stimulating the differentiation of keratinocytes include, for example, minerals such as calcium; sea fennel, a peptide extract of lupine such as that marketed by Silab under the trademark Structurine; sodium beta-sitosteryl sulphate, such as that sold by Seporga under the trade name Phytocohésine; and a water-soluble corn extract such as that marketed by SOLABIA under the trade name Phytovityl; a peptide extract of Voandzeia substerranea such as that marketed by Laboratoires Sérobiologiques under the trademark Filladyn LS 9397; and lignans such as secoisolariciresinol, retinol and its esters including retinyl palmitate.

As agents stimulating proliferation and / or differentiation of keratinocytes, there may be mentioned estrogens such as estradiol and homologues; cytokines.

As active agents stimulating the proliferation of fibroblasts or keratinocytes and / or the differentiation of the preferred keratinocytes, mention may be made of plant proteins or polypeptides, extracted especially from soybean (for example a soybean extract marketed by the company LSN under the name Eleseryl SH- VEG 8 or marketed by SILAB under the trade name Raffermine); an extract of hydrolysed soy protein such as SILAB RIDULISSE; a peptide extract of hazelnut such as that marketed by Solabia under the name Nuteline 00; adenosine; phloroglucinol, a yeast extract such as CLR Stimoderm; a peptide extract of lupine such as that marketed by SILAB under the trademark Structurine; a water-soluble corn extract such as that marketed by SOLABIA under the trade name Phytovityl; a peptide extract of Voandzeia substerranea such as that marketed by Laboratoires Sérobiologiques under the trademark Filladyn LS 9397; retinol and its esters, including retinyl palmitate. 40 10. Ages promoting the maturation of the horny envelope

In the compositions of the invention, it will be possible to use agents which mediate the maturation of the horny envelope which changes with age and induces a decrease in the activity of transglutaminases. There may be mentioned, for example, urea and its derivatives and in particular Hydrovance from National Starch and the other active agents mentioned in L'OREAL application FR2877220 (unpublished). . NO-synthase inhibitors

The agent having a NO synthase inhibitor action may be chosen from OPCs (procyanidolic oligomers); plant extracts of the Vitis vinifera species, sold in particular by the company Euromed under the name leucocyanidines of extra grapes, or by the company Indena under the name Leucoselect, or finally by Hansen under the name grape marc extract; plant extracts of the species Olea europaea preferably obtained from olive leaves and in particular marketed by VINYALS in the form of dry extract, or by Biologia & Technologia under the trade name Eurol BT; the extracts of a plant of the species Gingko biloba preferably a dry aqueous extract of this plant sold by Beaufour under the trade name Ginkgo biloba standard extract and mixtures thereof. 12. Benzodiazepine Peripheral Receptor Antagonists (ACBs)

For example, 1- (2-chlorophenyl) -N- (1-methylpropyl) -3-isoquinoline carboxamide may be mentioned; the compounds described in WO03 / 030937, WO03 / 068753, pyridazino [4,5-b] indole-1-acetamide derivatives of general formula (VII) as described in document WO00 / 44384.

13. Agents Increasing the Activity of the Sebaceous Gland Mention may be made, for example, of methyl dehydrojasmonate, hecogenin, hedione, o-linoleyl-6D-glucose and mixtures thereof.

14. Actives stimulating the energetic metabolism of the cells The active agent stimulating the energetic metabolism of the cells can for example be chosen from biotin, an extract of Saccharomyces cerevisiae such as Sederma's Phosphovital, the mixture of sodium salts, of manganese, of zinc and magnesium of pyrrolidone carboxylic acid such as Physiogenyl of Solabia, a mixture of zinc gluconate, copper and magnesium such as Sepitonic M3 Seppic and mixtures thereof; beta-glucan derived from Saccharomyces cerevisiae such as that marketed by Mibelle AG Biochemistry;

15. Tensioning agents By tensing agent that can be used according to the invention is meant compounds that can have a tensor effect, that is to say, that can tend the skin. In general, the term "tensioning agent" according to the invention means any compounds that are soluble or dispersible in water at a temperature ranging from 25 ° C. to 50 ° C. at a concentration of 7% by weight in water or at the maximum concentration. to which they form a medium of homogeneous appearance and producing at this concentration of 7% or at this maximum concentration in water a shrinkage of more than 15% in the test described below. The maximum concentration at which they form a homogeneous appearance medium is determined to within 10% and preferably to within 5%. By 'homogeneous appearance medium' is meant a medium which does not have aggregates visible to the naked eye.

For the determination of the said maximum concentration, the tensioning agent is gradually added to the water with stirring at the deflocculator at a temperature ranging from 25 ° C. to 50 ° C., and the mixture is then stirred for one hour. It is then observed after 24 hours if the mixture thus prepared is of homogeneous appearance (absence of aggregates visible to the naked eye). The tensor effect can be characterized by an in vitro retraction test. A homogeneous mixture of the tensioning agent in water, at the concentration of 7% by weight or at the maximum concentration defined above, is prepared beforehand and as described above. 30 μl of the homogeneous mixture is deposited on a rectangular test piece (10 × 40 mm, thus having an initial width LO of 10 mm) of elastomer having a modulus of elasticity of 20 MPa and a thickness of 100 μm. After drying for 3 hours at 22 ° C. and 40% relative humidity RH, the elastomer specimen has a retracted width, noted L 3h, due to the tension exerted by the tensioning agent deposited.

The tensor effect (ET) of said agent is then quantified as follows:

ET '= (LO û L3h / LO) x100 at 25 with Lo = initial width 10mm and L3h = width after 3h of drying The tensioning agent can be chosen from: vegetable or animal proteins and their hydrolysates; polysaccharides of natural origin; mixed silicates; colloidal particles of inorganic fillers; synthetic polymers; And mixtures thereof.

Those skilled in the art will be able to choose, in the chemical categories listed above, the materials corresponding to the tensor test as described above.

In particular, mention may be made of: (a) proteins and hydrolysates of vegetable proteins, in particular of maize, rye, wheat, buckwheat, sesame, peel, pea, bean, lentil, soybean and of lupine,

(B) polysaccharides of natural origin, in particular (a) polyholosides, for example (i) in the form of starch obtained in particular from rice, maize, potato, cassava, pea, wheat, oats, etc ... or (ii) in the form of carrageenans, alginates, agars, gellans, cellulosic polymers and pectins, advantageously in aqueous dispersion of gel microparticles, and (b) the latexes constituted by the shellac resin, the sandaraque gum, dammars, elemis, copals, cellulosic derivatives, and mixtures thereof,

(c) mixed silicates, in particular phyllosilicates and in particular Laponites,

(d) the colloidal particles of inorganic filler having a number average diameter of between 0.1 and 100 nm, preferably between 3 and 30 nm, and chosen for example from: silica, silica-alumina composites, oxide cerium, zirconium oxide, alumina, calcium carbonate, barium sulfate, calcium sulfate, zinc oxide and titanium dioxide. As silica-alumina composite colloidal particles that can be used in the compositions according to the invention, mention may be made, for example, of those sold by the company Grace under the names Ludox AM, Ludox AM-X 6021, Ludox HSA and Ludox TMA.

(e) synthetic polymers, such as polyurethane latices or acrylic-silicone latices, in particular those described in patent application EP-1038519, such as a propylthio (methyl polyacrylate), propylthio grafted polydimethyl siloxane ( polymethyl methacrylate) and propylthio (methacrylic acid), or a polydimethyl siloxane grafted propylthio (isobutyl polymethacrylate) and propylthio (methacrylic acid). Such grafted silicone polymers are especially sold by the company 3M under the trade names VS 80, VS 70 or LO 21. The tensing agent will be present in the composition in an amount effective to obtain the biological effect sought according to the invention. By way of example, the tensioning agent may be included in the composition according to the invention in a content ranging from 0.01% to 30% by weight of active material, preferably from 10% to 30% by weight of active ingredient, relative to the total weight of the composition.

The term "active material" is intended to exclude the medium in which the tensioning agent is optionally solubilized or dispersed in its commercial form, for example in the case of dispersions of colloidal particles.

It is also possible to use, especially to complement and / or potentiate the effect of tensors, use agents increasing the expression of mechanoreceptors, such as agents increasing the expression of integrins. By way of example, mention may be made of a rye seed extract, such as the product marketed by SILAB under the name Coheliss.

16. Liporestructuring agents

According to the invention, the term "liporestructive agents" means agents capable of stimulating lipogenesis and promoting adipocyte differentiation, thus making it possible to prevent or slow down the melting of the fats contained in the skin support tissues, otherwise known as `melting lipostructure of the skin '. By "lipo-structure of the skin" is meant the network of lipid cells which forms the volumes on which the skin of the face rests and molds.

These agents are intended to reduce the loss of skin density and / or the melting of the lipostructure of the skin, in particular at the level of the cheeks and the contour of the eye, and / or to prevent sagging and / or deepening of facial volumes, loss of skin consistency and / or maintenance, especially in the cheeks and around the eye, and / or improving the volumes underlying the facial skin and / or neck, especially the cheeks, the oval of the face and the contour of the eye, and / or improve the density, the rebound and the maintenance of the skin, especially in the cheeks, the oval of the face and the contour of the eye, and / or reshape the features of the face, in particular the oval of the face.

Examples of liporestructuring agents that may be mentioned include a black tea extract, such as the fermented black tea extract marketed by Sederma under the name Kombuchka, and an extract of Artemisia abrotanum, such as the one sold by Sllab under the name Pulpactyl.

17. Slimming agents As slimming agents (lipolytics), mention may be made in particular of caffeine, theophylline and its derivatives, theobromine, sericin, asiatic acid, acefylline, aminophylline, chloroethyltheophylline, diprofylline, diniprophylline, etamiphylline and its derivatives, etofylline, proxyphylline; tea, coffee, guarana, mate, cola (Cola Nitida) extracts and in particular the dry extract of guarana fruit (Paulina sorbilis) containing 8 to 10 caffeine; extracts of climbing ivy (Hedera Helix), arnica (Arnica Montana L), rosemary (Rosmarinus officinalis N), marigold (Calendula officinalis), sage (Salvia officinalis L), ginseng (Panax ginseng), 30 St. John's Wort (Byperycum Perforatum), Common Rump (Ruscus aculeatus L), Ulmaria (Filipendula ulmaria L), Orthosiphon (Orthosiphon Stamincus Benth), Birch (Betula alba), Cécropia and Argan tree; ginkgo biloba extracts, horsetail extracts, escin extracts, cangzhu extracts, chrysanthellum indicum extracts, diosgenin-rich dioscorate extracts or pure diosgenin or hecogenin and derivatives thereof, Ballot extracts , extracts of Guioa, Davallia, Terminalia, Barringtonia, Trema, Antirobia, the extract of petit grain of bigarrade; an extract of hulls of cocoa beans (theobroma cacao) such as that marketed by Solabia under the name Caobromine. 18. Agents promoting microcirculation of the skin

The active agent acting on the cutaneous microcirculation may be used to prevent dulling of the complexion and / or to improve the appearance of the contour of the eye, in particular to reduce dark circles. It may be chosen, for example, from a maritime pine bark extract such as Pycnogenol from Biolandes, manganese gluconate (Givobio GMn from Seppic), an extract from Ammi visnaga, such as Visnadine from Indena, extract from lupine (Eclaline de Silab), hydrolyzed wheat protein / palmitic acid coupling with palmitic acid such as Epaline 100 5o Carilene Laboratories, Bitterberry flower extract (Silab remodulin), vitamin P and its derivatives as the sodium methyl-4 esculetol mono-ethanoate sold under the name Permethol by Sephytal, extracts of ruscus, horse chestnut, ivy, ginseng and sweetclover, caffeine, nicotinate and its derivatives, lysine and its derivatives such as Solabia Asparlyne, a black tea extract such as Sederma Kombuchka; rutin salts: an extract of algae corallina officinalis such as that marketed by CODIF; and their mixtures.

Preferred agents for promoting cutaneous microcirculation are caffeine, a bigarade flower extract, black tea extract, rutin salts, coralline officinalis seaweed extract.

19. Soothing or anti-irritant agents

By soothing agent is meant a compound to reduce the sensation of tingling, itching or tightness of the skin.

As soothing agents that may be used in the composition according to the invention, mention may be made of: procyannidol oligomers, vitamins E, C B5, B3, caffeine and its derivatives, pentacyclic triterpenes and plant extracts containing them, acid b-glycyrrhetinic acid and its salts or derivatives (stearyl glycyrrhetate, 3-stearoyloxy glycyrrhetic acid, glycyrrhetinic monoglucuronide acid) and the plants containing it (eg Glycyrrhiza glabra), oleanolic acid and its salts, ursolic acid and its salts, boswellic acid and its salts, betulinic acid and its salts, an extract of Paeonia suffruticosa and / or lactiflora, an extract of Laminaria saccharina, extracts of Centella asiatica, canola oil bisabolol, vitamin E and C diesterphosphoric acid, such as Seppic's Sepivital EPC, chamomile extracts, allantoin, omega 3 unsaturated oils such as rosehip, blackcurrant, ecchium, po isson, calophilum oil, plankton extracts, capryloyl glycine, a mixture of water lily flower extract and palmitoylproline such as that sold under the name "Seppicalm VG" by Seppic, an extract of Boswellia serrata an extract of Centipeda cunnighami such as that sold under the name "Cehami PF" by the company TRI-K Industries, an extract of sunflower seeds, in particular Silab's helioxin, an extract of linum usitatissimum seeds such as Sensiline; of Silab, tocotrienols, piperonal, an extract of Epilobium angustifolium such as that sold under the name "Canadian Willowherb Extract" by the company FYTOKEM PRODUCTS, aloe vera, phytosterols, 40 blueberry water, rose water, a mint extract, in particular mint leaves such as Silab's Calmiskin, anise derivatives, filamentous bacteria such as Vitreoscilla filiformis as described in patent EP 761 204 and marketed by Chimex under the name Mexoryl SBG, an extract of rose petals such as the Rose Flower Herbasol extract of the company Cosmetochem, shea butter, a mixture of barley seed wax fraction obtained by supercritical CO2, butter shea and argan oil such as "Stimu-tex AS" from Pentapharm, alkaline earth salts including strontium, a fermented extract of Alteromonas marketed under the name ABYSSINE by the company Atrium Biotechnologies; the thermal waters of the Vichy basin, such as the waters from Celestins, Chomel, Grande-Grille, Hôpital, Lucas and Parc, and preferably Lucas spring water; an extract of Eperua falcata bark such as that marketed by the company COGNIS under the name Eperuline; an extract of Paeonia suffructicosa root such as that marketed by the company Ichimaru Pharcos under the name Botanpi Liquid B; and their mixtures.

As preferred soothing agents according to the invention, use will be made of: b-glycyrrhetinic acid and its salts or derivatives (stearyl glycyrrhetate, 3-stearoyloxy glycyrrhetic acid, glycyrrhetinic monoglucuronide acid) and the plants containing it ( eg Glycyrrhiza glabra); ursolic acid and its salts; extracts of Centella asiatica, canola oil, bisabolol; chamomile extracts, allantoin; a mixture of water lily flower extract and palmitoylproline such as that sold under the name "Seppicalm VG" by Seppic; aloe vera, rose water, mint extract, in particular mint leaves such as Silab's Calmiskin, filamentous bacteria such as Vitreoscilla filiformis as described in patent EP 761 204 and marketed by Chimex under the name Mexoryl SBG, an extract of rose petals such as the Rose Flower Herbasol extract from Cosmetochem, shea butter, a fermented extract of Alteromonas marketed under the name ABYSSINE by Atrium Biotechnologies; the thermal waters of the Vichy basin, such as the waters from Celestins, Chomel, Grande-Grille, Hôpital, Lucas and Parc, and preferably Lucas spring water; an extract of Eperua falcata bark such as that marketed by COGNIS under the name Eperuline; an extract of Paeonia suffructicosa root such as that marketed by the company Ichimaru Pharcos under the name Botanpi Liquid B; and their mixtures.

20. Sebo-regulator or anti-seborrhoeic agents

By "sebo-regulating or anti-seborrhoeic agents" is meant in particular agents capable of regulating the activity of the sebaceous glands.

These include: retinoic acid, benzoyl peroxide, sulfur, vitamin B6 (or pyridoxine), selenium chloride, sea fennel; mixtures of cinnamon extract, tea and octanoylglycine such as Sepicontrol A5 TEA from Seppic; 40 - the mixture of cinnamon, sarcosine and octanoylglycine, marketed in particular by the company SEPPIC under the trade name Sepicontrol A5; zinc salts such as zinc gluconate, zinc pyrrolidone carboxylate (or zinc pidolate), zinc lactate, zinc aspartate, zinc carboxylate, zinc salicylate, zinc cysteate ; copper derivatives and in particular copper pidolate such as Cuivridone from Solabia; extracts of plants of the species Arnica montana, Cinchona succirubra, Eugenia caryophyllata, Humulus lupulus, Hypericum perforatum, Mentha piperita, Rosmarinus officinalis, Salvia oficinalis and Thymus vulgaris, all sold for example by the company MARUZEN; - meadowsweet extracts (Spiraea ulamaria) such as that sold under the name Sébonormine by the company Silab; algae extracts laminaria saccharina such as that sold under the name Phlorogine by the company Biotechmarine; mixtures of extracts of burnet root (Sanguisorba officinalis / Poterium officinale), rhizomes of ginger (Zingiber officinalis) and cinnamon bark (Cinnamomum cassia), such as that sold under the name Sebustop by the company Solabia; linseed extracts such as the one sold under the name Linumine by the company Lucas Meyer; extracts of Phellodendron such as those sold under the name Phellodendron extract BG by the company Maruzen or Oubaku liquid B by the company Ichimaru Pharcos; mixtures of argan oil, of Serenoa serrulata (saw palmetto) extract and of sesame seed extract, such as that sold under the name Regu SEB by the company Pentapharm; mixtures of extracts of willowweed, terminalia chebula, nasturtium and bioavailable zinc (microalgae), such as the product sold under the name Seborilys by the green tech company; extracts of Pygeum afrianum, such as that sold under the name Pygeum afrianum sterolic lipid extract by the company Euromed; extracts of serenoa serrulata such as those sold under the name Viapure Sabal by the company Actives International, or those sold by the company Euromed; mixtures of extracts of plantain, berberis aquifolium and sodium salicylate, such as the product sold under the name Seboclear by the company Rahn; Clove extract, such as that sold under the name Clove extract powder by the company Maruzen; argan oil such as that sold under the name Lipofructyl by Serobiological Laboratories; the lactic protein filtrates, such as the product sold under the name Normaseb by the company Sederma; extracts of alga Laminaria, such as that sold under the name Laminarghane by the company Biotechmarine; oligosaccharides of algae laminaria digitata such as that sold under the name Phycosaccharide AC by the company Codif; 40 - cane sugar extracts such as the product sold under the name Policosanol by Sabinsa; sulphonated shale oil, such as that sold under the name Ichtyol Pale by the company Ichthyol; - extracts of ulmaire (spiraea ulmaria) such as that sold under the name Cytobiol Ulmaire by the company Libiol; sebacic acid, in particular sold in the form of a sodium polyacrylate gel under the name Sebosoft by Sederma; glucomannans extracted from konjac tubers and modified with alkylsulphonate chains, such as the one sold under the name Biopol Beta by the company Arch Chemical; extracts of Sophora angustifolia, such as those sold under the name Sophora powder or Sophora extract by the company Bioland; extracts of Cinchona succirubra bark such as that sold under the name Red Bark HS by the company Alban Muller; extracts of quillaja saponaria, such as the product sold under the name Panama wood HS by Alban Muller; glycine grafted on an undecylenic chain, such as that sold under the name Lipacide UG OR by the company Seppic; the mixture of oleanolic acid and nordihydroguaiaretic acid, such as that sold in the form of a gel under the name AC.Net by the company Sederma; Phthalimidoperoxyhexanoic acid; trialkyl citrate (C12-C13) sold under the name COSMACOL ECI by the company Sasol; trialkyl citrate (C14-C15) sold under the name COSMACOL ECL by the company Sasol; 10-hydroxydecanoic acid, and in particular mixtures of 10-hydroxydecanoic acid, of sebacic acid and of 1,10-decandiol, such as that sold under the name Acnacidol BG by the company Vincience; and - their mixtures. Preferred anti-seborrhoeic active agents include: benzoyl peroxide, vitamin B6 (or pyridoxine), zinc salts such as zinc gluconate, zinc pyrrolidone carboxylate (or zinc pidolate), zinc lactate, zinc aspartate, zinc carboxylate, zinc salicylate, zinc cysteate; - meadowsweet extracts (Spiraea ulamaria) such as that sold under the name Sébonormine by the company Silab; algae extracts laminaria saccharina such as that sold under the name Phlorogine by the company Biotechmarine; Mixtures of extracts of burnet root (Sanguisorba officinalis / Poterium officinale), of ginger rhizomes (Zingiber officinalis) and of cinnamon bark (Cinnamomum cassia), such as that sold under the name Sebustop by the company Solabia; clove extract, such as that sold under the name Clove 35 extract powder by the company Maruzen; lactic protein filtrates, such as the product sold under the name Normaseb by the company Sederma; - extracts of ulmaire (spiraea ulmaria) such as that sold under the name Cytobiol Ulmaire by the company Libiol; Sebacic acid, especially sold in the form of a sodium polyacrylate gel under the name Sebosoft by Sederma; glycine grafted on an undecylenic chain, such as that sold under the name Lipacide UG OR by the company Seppic; trialkyl citrate (C12-C13) sold under the name COSMACOL 45 ECI by the company Sasol; trialkyl citrate (C14-C15) sold under the name COSMACOL ECL by the company Sasol; 10-hydroxydecanoic acid, and in particular mixtures of 10-hydroxydecanoic acid, of sebacic acid and of 1,10-decandiol, such as that sold under the name Acnacidol BG by the company Vincience; 50 - and their mixtures.

Preferably, the anti-seborrhoeic active agent is chosen from: zinc salts such as zinc gluconate, zinc pyrrolidone carboxylate (or zinc pidolate), zinc lactate, zinc aspartate, carboxylate, zinc, zinc salicylate, zinc cysteate; and preferably zinc pyrrolidone carboxylate (or zinc pidolate) or zinc salicylate; clove extract, such as that sold under the name Clove Extract Powder by the company Maruzen; glycine grafted on an undecylenic chain, such as that sold under the name Lipacide UG OR by the company Seppic; trialkyl citrate (C12-C13) sold under the name COSMACOLO ECI by the company Sasol; trialkyl citrate (C14-C15) sold under the name COSMACOLO ECL by the company Sasol; - and their mixtures. The anti-seborrhoeic active agent is, for example, present in a content ranging from 0.1 to 10% by weight, preferably from 0.1 to 5% by weight, and preferably from 0.5% to 3% by weight. relative to the total weight of the composition.

21. Astringent agents

By "astringent agents" is meant according to the invention agents for controlling the dilation of the sebaceous follicles.

As astringent agents that may be used in the composition according to the invention, mention may be made of extracts of mushroom pulp (polyporus officinalis) such as "Laricyl LS88650" from Cognis, extracts of Terminalia catappa and sambucus nigra such as Phytofirm LS91200 from Cognis, gallonum extracts such as Ichimaru Pharcos Tanlex VE0, aluminum hydroxychloride, centella extracts (ex Plantactiv centella of Cognis), diketyl dimethyl ammonium chloride such as Degussa's Varisoft 432 CG, extracts chestnut extracts, extracts of Hammamelis, extracts of sweet almonds, marshmallow roots and flax seeds such as Almondermin LS 3380 from Cognis, extracts of burdock, extracts of nettle, birch extracts, horsetail extracts, chamomile extracts such as those sold under the name Extrapone 9 special by Symrise, scutellaria extracts, Ulmaire extracts (e.g. e Cytobiol Ulmaire de Libiol), a blend of extracts of white ginger, horsetail, nettle, rosemary, yucca such as Herb extract B1348 from Bell flavors & fragrances, 40 acacia extracts, elm, white willow, cinnamon, birch, meadowsweet, panama sapogenins, interchemical zinc phenolsulfonate, gentian extracts, cucumber, walnut, mixture of extracts of Ratanhia, grapefruit , grindelia and oak gall as Alban Muller's Epilami0. Preferred astringent agents according to the invention are scutellaria extracts, ulmary extracts, close-up queen extracts, gentian extracts, burdock extracts and mixtures thereof. 22. Healing agents Examples of healing agents that may be mentioned include: allantoin, urea, certain amino acids such as hydroxyproline, arginine, serine, and also extracts of white lily (such as Phytelene Lys 37EG 16295 from Indena), a yeasts extract such as the healing wound LS LO / 7225B from Laboratoires Sériobiologiques), tamanu oil, Saccharomyces cerevisiae extract such as Biodynes TRF from Arch Chemical, oat extracts, chitosan and derivatives such as chitosan glutamate, carrot extracts, artemia extract such as Vincience GP4G, sodium acexamate, lavandin extracts, propolis extracts, ximeninic acid and its salts , rosa rugosa oil, marigold extracts such as Alban Muller's Fruci Ami Liposolible, horsetail extracts, lemon bark extracts such as Cosmetochem's lemon Herbasol, extracts of helichryse, extracts of millefeuilles, and folic acid.

Preferred healing agents according to the invention will be arginine, serine, folic acid, tamanu oil, sodium acexamate, horsetail extracts, helichryse extracts, and mixtures thereof. 23. Anti-inflammatory agents

As particular antiinflammatory agents that can be used according to the invention, mention may be made of cortisone, hydrocortisone, indomethacin, betamethasone, azealic acid, acetaminophen, diclofenac, clobetasol propionate and folic acid. ; an extract of Eperua falcata bark such as that marketed by the company COGNIS under the name Eperuline; an extract of Paeonia suffructicosa root such as that marketed by the company Ichimaru Pharcos under the name Botanpi Liquid B; and their mixtures.

As a preferred anti-inflammatory agent, there will be mentioned azelaic acid, folic acid, an extract of Eperua falcata bark such as that marketed by the company COGNIS under the name Eperuline; an extract of Paeonia suffructicosa root such as that marketed by the company Ichimaru Pharcos under the name Botanpi Liquid B; and their mixtures. 24. Anti-acne agents

In an advantageous aspect of the invention, the composition may further comprise at least one anti-acne active agent.

By "anti-acne active" is meant any active having effects on the specific flora of oily skin such as for example Propionibacterium acnes (P acnes).

These effects can be bactericidal.

As anti-bactericidal active agents, mention may in particular be made of: the active agents and preservatives with antimicrobial activity mentioned in the application DE10324567, incorporated in the present invention by reference, the Asian acid, the monoethanolamine salt of the hydroxy-4-methyl-6-trimethylpentyl-2-pyridone (INCI name: piroctone olamine), sold especially under the name Octopirox by Clariant; citronellic acid, pericylic acid (or 4-isopropenylcyclohex-1-enecarboxylic acid), and 2-ethyl hexyl glycerol ether (INCI name: ethylhexylglycerine), for example sold under the name Sensiva SC 50 by the company Shulke & Mayr, caprylate / glyceryl caprate, for example sold under the name io Capmul MCM by the company ABITEC; calcium and sodium phosphosilicate, sold in particular under the names Bioactive glasspowder and Actysse Premier BG by the company Schott Glass; silver-based particles, for example those sold under the name Metashine ME 2025 PS by the company Nippon Sheet Glass; the hop cone extract (Humulus Lupulus) obtained by supercritical CO2 extraction, such as that sold under the name HOP CO2-TO extract by Flavex Naturextrakte, the extract of Millepertius obtained by supercritical CO2 extraction such as that sold under the name ST John's Wort CO2-TO extract by the company Flavex Naturextrakte, - the mixture of extracts of roots of scutellaria baicalensis, of paeonia suffruticosa and of glycyrrhiza glabra, such as that sold under the name BMB-CF by the company Naturogin, 25 - argan extract such as Argapure LS9710 from COGNIS; - bearberry leaf extracts such as the one sold under the name "Melfade-J" by Pentapharm; 10-hydroxy-2-decanoic acid, such as Acnacidol P from Vincience, sodium ursolate, azelaic acid, di-iodomethyl p-tolylsulfone such as Flowable Friendly from Angus malachite powder, zinc oxide such as Zincare from Elementis GMBH, octadecenedioic acid such as Arlatone dioic DCA from Uniqema; ellagic acid; 2,4,4'-trichloro-2'-hydroxy diphenyl ether (or triclosan), 1- (3 ', 4'-dichlorophenyl) -3- (4'-chlorophenyl) urea (or triclocarban), 3 4,4'-trichlorocarbanilide, 3 ', 4', 5'-trichlorosalicylanilide, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, hexamidine isethionate, metronidazole and its salts, miconazole and its salts, itraconazole , terconazole, econazole, ketoconazole, saperconazole, fluconazole, clotrimazole, butoconazole, oxiconazole, sulfaconazole, sulconazole, terbinafine, ciclopirox, 40 ciclopiroxolamine, undecylenic acid and its salts , benzoyl peroxide, 3-hydroxy benzoic acid, 4-hydroxy benzoic acid, phytic acid, N-acetyl-L-cysteine, lipoic acid, azelaic acid and its salts, arachidonic acid, resorcinol, 3,4,4'-trichlorocarbanalide, octoxyglycerine or octoglycerine, octanoylglycine such as Seppic's 45 Lipacid C8G, caprylyl glycol, 10-hydroxy-2-decanoic acid, dichlorophenyl imidazol dioxolan and its derivatives described in patent application WO9318743, iodopropynyl butylcarbamate, 3,7,11-trimethyldodeca-2,5,10-trienol or farnesol, phytosphingosines ; quaternary ammonium salts such as cetyltrimethylammonium salts, cetylpyridinium salts, and mixtures thereof.

Mention may also be made of certain surfactants having an antimicrobial effect such as cocoampho sodium acetate or diacetate disodium such as Miranol C2M CONC NP, betaines such as cocoyl betaine Genagen KB from Clariant, sodium lauryl ether sulfate such as Emal 270 D of Kao, decyl glucoside such as Plantacare 2000 UP, maleate of branched C12-13 dialcohols such as Cosmacol EMI, monoesters of propylene glycol such as monolaurate, monocaprylate, propylene glycol monocaprate, lauryl dimethylamine betaine such as Empigen BB / LS as well as quaternary polyammoniums such as Quaternium-24 or Bardac 2050 from Lonza and those described in patent FR 0 108 283 and mixtures thereof.

As preferred antimicrobial agents, an agent selected from octoglycerin or octoxyglycerin, 10-hydroxy-2-decanoic acid, and mixtures thereof, will be used in the compositions of the invention.

Other additional anti-acne active agents may be added to the aforementioned anti-acne active agents. It is possible to cite the active agents having bacterial anti-adhesion effects or acting on the biofilm of the bacteria to prevent their multiplication.

As agents which prevent and / or reduce the adhesion of microorganisms, mention may be made in particular of: phytanetriol and its derivatives as described in patent application EP 1 529 523, vegetable oils such as coconut oil, wheat, marigold oil, castor oil, olive oil, avocado oil, sweet almond oil, peanut oil, jojoba oil, sesame oil, apricot kernel oil, sunflower oil, macadamia oil, described in patent EP 1 133 979, or certain surfactants such as disodium cocoamphodiacetate, cocoamphodiacetate, oxyethylenated glyceryl (70E), hexadecenylsuccinate 18, octoxyglyceryl palmitate, octoxyglyceryl behenate, dioctyl adipate, PPG-15 stearyl ether, branched C12-C13 di-alcohol tartrate described in US Pat. EP 1 129 694 and mixtures thereof. In particular with regard to the propagation of P acnes, or as active agents acting on the biofilm of bacteria to prevent their proliferation, mention may be made of pentylene glycol, nylon-66 (polyamide 66 fibers), rice bran oil, polyvinyl alcohol such as Celvol 540 PV alcohol from Celanese Chemical, rapeseed oil such as Akorex L from Karlshamns, and fructose derivatives and mixtures thereof.

The active ingredient against acne may be present in a content ranging from 0.01 to 45% by weight, preferably from 0.05 to 5% by weight relative to the total weight of the composition.

Depending on the nature and / or the solubility of the aforementioned assets, a person skilled in the art will know how to choose the most suitable embodiment according to the invention. As lipophilic active agents which may be used in the kit or at least one of the compositions of the invention, mention may in particular be made of D-tocopherol, DL-tocopherol, D-tocopherol acetate and DL-atocopherol acetate. ascorbyl palmitate, vitamin F glycerides, vitamin D, vitamin D2, vitamin D3, retinol, retinol esters, retinol palmitate, retinol propionate, carotenes including R carotene, D panthenol, farnesol, farnesyl acetate, salicylic acid and its derivatives such as 5-n-octanoyl salicylic acid, alkyl esters of a hydroxy acids such as citric acid, lactic acid, acid glycolic, asiatic acid, madecassic acid, asiaticoside, the total extract of centella asiatica, R glycyrrhetinic acid, a bisabolol, ceramides such as 2-oleoylamino-1,3-octadecane, phytanetriol , phospholipids of marine origin rich in polyunsaturated essential fatty acids, ethoxy rosemary extract, melissa extract, quercetin, dried microalgae extract, bergamot essential oil, octylmethoxycinnamate, butylmethoxydibenzoylmethane, octyl triazone, di tertiobutyl-3, 5-hydroxy-4-benzylidene camphor, antibiotics, antifungals, anesthetics, analgesics, antiseptics, antivirals, pesticides, herbicides, and mixtures thereof.

The cosmetic and / or dermatological active agents will be present in the kit or one of the compositions according to the invention in a content ranging from 0.001% to 20% by weight relative to the total weight of the composition, preferably 0.01%. % to 10%, even more preferably from 0.5 to 5% and more preferably from 0.1 to 1% by weight relative to the total weight of the composition. For peeling applications, the contents of cosmetic and / or dermatological active agents may range from 1% to 50% by weight relative to the total weight of the composition, preferably from 1% to 30% by weight relative to the total weight of the composition. the composition. Peels are a well-known means for improving the appearance and / or texture of the skin and / or scalp, in particular to improve the radiance and homogeneity of the complexion and / or to reduce visible and / or tactile irregularities. skin, and in particular to improve the surface appearance of the skin, to reduce actinic lentigo, marks of acne or chickenpox, as well as to prevent, attenuate or fight against the signs of skin aging, and in particular to smooth irregularities in the texture of the skin, such as wrinkles and fine lines.

They have the effect of removing a superficial part of the skin to be treated (epidermis 40 and possibly superficial layer of the dermis) by chemical methods.

OTHER ADDITIONAL INGREDIENTS

In order to complement and / or optimize the effects conferred by the cosmetic and / or dermatological active agents mentioned above on keratin materials, it may be advantageous to incorporate other additional ingredients into the compositions of the invention.

In particular, these additional ingredients may confer an immediate visual effect that will be relayed by the biological effect of the assets mentioned above. They can also, through a mechanical action (eg abrasvies), amplify the effect of the biological assets mentioned above.

Thus, the composition according to the invention may also comprise at least one agent chosen from matting agents, blooming fillers, fluorescent agents, agents which promote the naturally rosy coloration of the skin, abrasive fillers or exfoliating agents, and their mixtures.

Matifying Agents "Matifying agent" means agents intended to make the skin visibly duller and less glossy.

The matting effect of the agent and / or of the composition containing it may in particular be evaluated using a gonioreflectometer, by measuring the ratio R between the specular reflection and the diffuse reflection. A value of R less than or equal to 2 generally reflects a matting effect.

The matting agent may especially be chosen from a rice starch or a maize starch, kaolinite, talc, an extract of pumpkin seeds, cellulose microbeads, vegetable fibers, synthetic fibers, in particular polyamides , microspheres of expanded acrylic copolymers, polyamide powders, silica powders, polytetrafluoroethylene powders, silicone resin powders, acrylic polymer powders, wax powders, polyethylene powders, powders of crosslinked organopolysiloxane elastomer coated with silicone resin, talc / titanium dioxide / alumina / silica composite powders, amorphous mixed silicate powders, silicate particles and in particular mixed silicate, and mixtures thereof. Examples of matting agents that may be mentioned include: rice or maize starch, in particular an aluminum starch octenyl succinate sold under the name Dry Flo by the company National Starch, kaolinite; - silicas; - letalc; an extract of pumpkin seeds as marketed under the name Curbilene by the company Indena; Cellulose microbeads as described in patent application EP 1 562 562; - fibers, such as silk, cotton, wool, flax, cellulose fibers extracted from wood, vegetables or algae, polyamide (nylon), modified cellulose, poly-p-phenylene terephtamide , in acrylic, polyolefin, glass, silica, aramid, carbon, Teflon, insoluble collagen, polyesters, polyvinyl chloride or vinylidene, polyvinyl alcohol, polyacrylonitrile, chitosan, polyurethane, polyethylene phthalate, fibers formed from a mixture of polymers, synthetic resorbable fibers, and mixtures thereof described in the patent application EP 1 151 742; microspheres of expanded acrylic copolymers such as those sold by EXPANCEL under the trade names EXPANCEL 551, fillers with an optical effect as described in patent application FR 2 869 796, in particular: polyamide powders ( Nylon), such as Arkema's Orgasol-type nylon 12 particles having a mean size of 10 microns and a refractive index of 1.54, silica powders, for example Silica beads SB150 of Miyoshi size. average 5 microns and refractive index 1.45, - powders of polytetrafluoroethylene, such as PTFE ceridust 9205F Clariant average size 8 microns and refractive index 1.36, - the silicone resin powders as the Silicon resin Tospearl 145A of GE Silicone of average size 4.5 microns and refractive index 1.41, 15 - powders of acrylic copolymers, especially of poly (meth) acrylate, such as PMMA particles J urymer MBI of Nihon Junyoki of average size 8 microns and refractive index 1.49, or the Micropearl M100 and F 80 EDO particles of the company Matsumoto Yushi-Seiyaku, - the wax powders such as paraffin wax microease particles 114S of 20 micropowders of average size 7 microns and refractive index 1.54, - polyethylene powders, especially comprising at least one ethylene / acrylic acid copolymer, and in particular consisting of ethylene / acrylic acid copolymers such as Flobeads particles EA 209 of Sumitomo (average size 10 microns and refractive index 1.48), elastomeric crosslinked organopolysiloxane powders coated with silicone resin, in particular silsesquioxane resin, as described for example in US Pat. No. 5,538,793 Such elastomer powders are sold under the names "KSP-100", "KSP-101", "KSP-102", "KSP-103", "KSP-104", "KSP-105" by company SHIN ETSU, and - the powders composi talc / titanium dioxide / alumina / silica, such as those sold under the name Coverleaf® AR-80 by the company Catalyst & Chemicals, - mixtures thereof, - compounds that absorb and / or adsorb sebum as described in the application for Patent FR 2 869 796. Mention may in particular be made of: silica powders, such as, for example, the porous silica microspheres sold under the name "Silica Beads SB-700" marketed by the company MYOSHI, the "SUNSPHERE H51", "SUNSPHERE" H33 ", 40" SUNSPHERE H53 "marketed by ASAHI GLASS; the polydimethylsiloxane-coated amorphous silica microspheres sold under the name "SA SUNSPHEREO H-33" and "SA SUNSPHEREO H-53" marketed by the company ASAHI GLASS; mixed amorphous silicate powders, in particular aluminum and magnesium, such as for example the one marketed under the name "NEUSILIN UFL2" by Sumitomo. polyamide (nylon) powders, for example "ORGASOL 4000" marketed by Arkema, and acrylic polymer powders, in particular of polymethyl methacrylate, such as for example the "COVABEAD LH85" marketed by the Company. WACKHERR company; polymethyl methacrylate / ethylene glycol dimethacrylate, such as, for example, "DOW CORNING 5640 MICROSPONGEO SKIN OIL ADSORBER" marketed by Dow Corning, or "Ganzpearl GMP-0820" marketed by Ganz Chemical; allyl polymethacrylate / ethylene glycol dimethacrylate, such as, for example, "POLY-PORE L200" or "POLY-PORE E200" marketed by AMCOL; ethylene glycol dimethacrylate / lauryl methacrylate copolymer, such as, for example, the "POLYTRAP 6603" sold by the company Dow Corning; silicate particles, such as alumina silicate; mixed silicate particles, such as: magnesium aluminum silicate particles, such as saponite or magnesium aluminum silicate, hydrated with a sodium sulphate sold under the trade name Sumecton® by the company Kunimine; the magnesium silicate complex, hydroxyethylcellulose, black cumin oil, squash oil and phospholipids or MatipureO from Lucas Meyer, and their mixtures. As preferred matting agents, it is possible to use according to the invention a pumpkin seed extract, a rice or maize starch, kaolinite, silicas, talc, polyamide powders, polyethylene powders, powders of acrylic copolymers, expanded acrylic copolymer microspheres, silicone resin microbeads, mixed silicate particles and mixtures thereof. 25 Loads with a flutter effect

These fillers can be any material capable of modifying the wrinkles by its intrinsic physical properties and of masking them. These fillers may especially modify the wrinkles by a tightening effect, a camouflaging effect, or a blurring effect.

As a filler, the following compounds can be exemplified: porous silica microparticles, for example Myochi's Silica Beads 35 SB 150 and SB 700 with an average size of 5 μm, and the Asahi series SUNSPHERESO H Glass, such as H33, H51 with a size of 3.5 and 5 μm respectively, and hollow hemispherical particles of silicone resins, such as NLK 500, NLK 506 and NLK 510 from Takemoto Oil and Fat, described in EP-A-1579849. silicone resin powders such as, for example, SILICON Resin TospearI 0.15 A DE GE silicone of average size of 4.5 μm. powders of acrylic copolymers, in particular of methyl poly (meth) acrylate, for example PMMA Jurimer MBIO particles of Nihon 45 Junyoki with an average size of 8 μm, the hollow spheres of PMMA sold under the name COVABEADO LH 85 by the company Wackherr and expanded vinylidene / acrylonitrile / methylene methacrylate microspheres sold under the name ExpanceI0. wax powders such as Paraffin wax microloase O 114S particles of 5 o Micropowders of average size of 7 μm. polyethylene powders in particular comprising at least one ethylene / acrylic acid copolymer, for example the FLOBEADSO EA 209 E from Sumimoto with an average size of 10 μm. crosslinked elastomeric organopolysiloxane powders coated with silicone resin, in particular silsesquioxane under the name KSP 100, KSP 1010, KSP 102, KSP 103, KSP 104 and KSP 105 by the company Shin Etsu. talc / dioxide or titanium / alumina / silica composite powders, such as for example Coverleaf AR 80 from Catalyst & Chemical. talc, mica, kaolin, lauryl glycine, starch powders crosslinked with octyanyl succinate anhydride, boron nitride, polytetrafluoroethylene powders, precipitated calcium carbonate, hydrocarbon carbonate, magnesium, barium sulfate, hydroxyapatite, calcium silicate, cerium dioxide and microcapsules of glass or ceramics. synthetic or natural hydrophilic or hydrophobic fibers, mineral or organic, such as fibers of silk, cotton, wool, flax, cellulose extracted especially from wood, vegetables or algae, polyamide (nylon), modified cellulose, poly-p-phenylene terephtamide, acrylic, polyolefin, glass, silica, aramid, carbon, polytetrafluoroethylene (Teflon), insoluble collagen, polyesters, polyvinyl chloride or vinylidene , polyvinyl alcohol, polyacrylonitrile, chitosan, polyurethane, polyethylene phthalate, fibers formed from a mixture of polymers, synthetic resorbable fibers, and mixtures thereof described in patent application EP 1 151 742. - spherical elastomeric crosslinked silicones such as Trefil E-505C or E-506 C from Dow Corning. abrasive fillers which, by a mechanical effect, provide a smoothing of the skin microrelief, such as abrasive silica, for example abrasive SPO from Semanez or powders of nuts or shells (apricot, walnut, for example from Cosmetochem).

The fillers having an effect on the signs of aging are chosen in particular from porous silica microparticles, hollow hemispherical silicone particles, silicone resin powders, acrylic copolymer powders, polyethylene powders, powders of crosslinked elastomeric organopolysiloxanes coated with silicone resin, talc / titanium dioxide / alumina / silica composite powders, precipitated calcium carbonate, magnesium hydrocarbonate carbonate, barium sulfate, hydroxyapatite, silicate calcium, cerium dioxide and microcapsules of glass or ceramics, silk fibers, cotton, and mixtures thereof.

45 The load can be a soft focus load. By soft-focus charge, we mean a charge which in addition gives transparency to the complexion and a fuzzy effect. Preferably, the soft-focus charges have an average particle size of less than or equal to 15 microns. These particles may be of any shape and in particular be spherical or non-spherical. More preferably, these fillers are nonspherical.

The soft-focus fillers may be chosen from silica and silicate powders, in particular alumina powders, polymethyl methacrylate (PMMA) powders, talc, silica / TiO2 or silica / zinc oxide composites, polyethylene powders starch powders, polyamide powders, styrene / acrylic copolymer powders, silicone elastomers, and mixtures thereof. In particular, mention may be made of talc with a mean size of less than or equal to 3 microns, for example talc with a mean size of 1.8 microns, and in particular that sold under the trade name Talc P3 by the company Nippon Talc. , Nylon 12 powder, in particular that sold under the name Orgasol 2002 Extra D Nat Cos by Atochem, silica particles treated on the surface with a mineral wax 1 to 2% (INCI name: hydrated silica (and) paraffin) such as those marketed by Degussa, amorphous silica microspheres, such as those sold under the name Sunsphere, for example reference H-53 by Asahi Glass, and silica micro-beads such as those sold under the name denomination SB-700 or SB-150 by the company Miyoshi, this list not being limiting. The concentration of these fillers having an effect on the signs of aging in the compositions according to the invention may be between 0.1 and 40%, or even between 0.1 and 20% by weight relative to the total weight of the composition. .

Fluorescent agents

Fluorescent agent is a substance which, under the effect of ultraviolet rays and / or visible light, re-emits in the visible the portion of light which it has absorbed in the same color as that which it reflects. naturally. The naturally reflected color is thus enhanced by the re-emitted color and appears extremely bright. Examples include polyamide and / or formaldehyde / benzoguanamine and / or melamine / formaldehyde / sulfonamide colored resins, among colored aminotriazine / formaldehyde / sulfonamide co-condensates and / or metallized polyester flakes and / or their mixtures. These fluorescent pigments may also be in the form of aqueous dispersions of fluorescent pigments.

Mention may also be made of the aminotriazine / formaldehyde / fluorescent colored sulphonamide co-condensate of medium size of the 3-4 micron particles sold under the trade name Fiesta Astral Pink FEX-1 and the cocondensate aminotriazine / formaldehyde / fluorescent sulphonamide colored in blue. of average size of the particles 3-4.5 microns sold under the trade name Fiesta Comet Blue FTX-60 by the company Swada or the benzoguanamine / formaldehyde resin coated with formaldehyde resin / urea 45 and colored yellow sold under the trade name FB -205 Yellow and the benzoguanamine / formaldehyde resin coated with formaldehyde / urea resin and colored red sold under the trade name FB-400 Orange Red by UK company SEUNG CHEMICAL, the orange colored polyamide resin sold under the trade name 50 Flare 911 Orange 4 by Sterling Industrial Colors.

The fluorescent substances are preferably present in the composition, at a content ranging from 0.1 to 20%, preferably from 0.1 to 15%, more preferably from 0.5 to 3% by weight, relative to the weight total of the composition. When the organic fluorescent substances are white, they are also called optical brighteners.

The optical brightener has the effect of enhancing the brightness and brightening the hues of the cosmetic compositions comprising them to the application on the skin. Among the optical brighteners, mention may be made more particularly of stilbene derivatives, in particular polystyrylstilbenes and triazinstilbenes, coumarin derivatives, in particular hydroxycoumarines and aminocoumarines, oxazole, benzoxazole, imidazole, triazole and pyrazoline derivatives, and derivatives thereof. Pyrene and porphyrin derivatives and / or mixtures thereof.

Such compounds are for example available under the trade names Tinopal SOPo and Uvitex OBo from CIBA GEIGY.

The optical brighteners preferentially used are sodium 4,4'-bis [(4,6-dianilino-1,3,5-triazin-2-yl) amino] stilbene-2,2'-disulfonate, 2, 5-thiophenediylbis (5-butyl-1,3-benzoxazole), di-styryl-4,4'biphenyl-di-sodium sulfonate and / or mixtures thereof.

Agents Promoting Naturally Rosy Coloring of the Skin In particular, mention may be made of:

a self-tanning agent, that is to say an agent which, applied to the skin, in particular on the face, makes it possible to obtain a tanning effect of a more or less similar appearance to that which may result from a prolonged exposure to the sun (natural tanning) or under a UV lamp; an additional coloring agent, that is to say any compound having a particular affinity for the skin, enabling it to give the latter a lasting, non-covering coloration (ie not having a tendency to opacify the skin); ) and which is eliminated with neither water nor with the aid of a solvent, and which is resistant to both rubbing and washing with a solution containing surfactants. Such durable coloration is therefore distinguished from the superficial and momentary coloration provided for example by a makeup pigment; 40 and mixtures thereof.

Examples of self-tanning agents that may be mentioned include: dihydoxyacetone (DHA), erythrulose, and the combination of a catalytic system formed of: salts and oxides of manganese and / or zinc, and alkaline hydrogencarbonates and or alkaline earth.

The self-tanning agents are generally chosen from mono or polycarbonyl compounds such as, for example, isatin, alloxane, ninhydrin, glyceraldehyde, mesotartaric aldehyde, glutaraldehyde, erythrulose, pyrazolin-4 derivatives, 5-diones as described in patent application FR 2,466,492 and WO 97/35842, dihydroxyacetone (DHA), 4,4-dihydroxypyrazolin-5-ones derivatives as described in patent application EP 903 342 DHA will preferably be used.

DHA may be used in free form and / or encapsulated for example in lipid vesicles such as liposomes, in particular described in application WO 97/25970. In general, the self-tanning agent is present in an amount ranging from 0.01 to 20% by weight, and preferably in an amount of between 0.1 and 10% of the total weight of the composition.

Other dyes that can modify the color produced by the self-tanning agent can also be used.

These dyes may be chosen from synthetic direct dyes or natural dyes. These dyes may be chosen, for example, from red or orange dyes of the fluoran type such as those described in the patent application FR2840806. Mention may be made, for example, of the following dyes: tetrabromofluorescein or eosin known under the name CTFA: Cl 45380 or Red 21 - phloxine B known under the name CTFA: Cl 45410 or Red 27 - diiodofluorescein known under the name CTFA Cl 45425 or Orange 10; dibromofluorescein known under the name CTFA: Cl 45370 or Orange 5. the sodium salt of tetrabromofluorescein known under the name CTFA: Cl 45380 (Na knows) or Red 22 - the sodium salt of phloxine B known under the CTFA name: Cl 45410 (Na knows) or Red 28 - the sodium salt of diiodofluorescein known as CTFA: Cl 45425 (Na knows) or Orange 11; Erythrosine known as CTFA: Cl 45430 or Acid Red 51. Phloxine known as CTFA: Cl 45405 or Acid Red 98.

These dyes may also be chosen from antraquinones, caramel, carmine, charcoal black, azulene blue, methoxalene, trioxalene, guajazulene, chamuzulene, bengal rose, cosine 10B, cyanosine, daphinin.

These dyes may also be chosen from indole derivatives such as the monohydroxyindoles as described in the patent FR2651126 (45 ie: 4-, 5-, 6- or 7-hydroxyindole) or the di-hydroxyindoles as described in the EP-patent. B-0425324 (ie: 5,6-dihydroxyindole, 2-methyl-5,6-dihydroxyindole, 3-methyl-5,6-dihydroxyindole, 2,3-dimethyl-5,6-dihydroxyindole);

Abrasive or exfoliating agents As exfoliants for use in rinsed compositions according to the invention, for example exfoliating or scrubbing particles of mineral, plant or organic origin may be mentioned. Thus, for example, beads or polyethylene powder, nylon powder, polyvinyl chloride powder, pumice, ground apricot kernels or nut shells can be used. sawdust, glass beads, alumina, and mixtures thereof. Exfogreen of Solabia (bamboo extract), extracts of strawberry akenes (Greentech strawberry Akenes), peach stone powder, apricot kernel powder, and finally In the field of abrasive-effect vegetable powders, mention is made of cranberry kernel powder.

Preferred abrasive fillers or exfoliating agents according to the invention are peach kernel powder, apricot kernel powder, cranberry kernel powder, strawberry achene extracts, bamboo extracts. .

The following examples serve to illustrate the invention. In these examples, the amounts of the ingredients compositions are given in% by weight relative to the total weight of the composition.

Example 1 - Preparation of (trimethylsilyl) methyl 5- (1,2-dithiolan-3-yl) pentanoate (Compound 1) In a 25 mL three-neck topped with a condenser and a thermometer, 4.23 g (20, 5 mmol) of 5- (1,2-dithiolan-3-yl) pentanoic acid and 2.9 ml (22.5 mmol) of (trimethylsilyl) methanol are introduced into 5 ml of toluene. 0.11 mL (2.05 mmol) of 98% sulfuric acid is added and then heated at T = 80 ° C. for 2.5 hours. At room temperature, the reaction medium is taken up in 100 ml of ethyl acetate and then washed with water and with a saturated solution of sodium chloride, the organic phase is dried over sodium sulfate, filtered and concentrated. under vacuum P = 240 mbar at 40 ° C. After purification on a silica column, heptane / ethyl acetate eluent: 95/5, 2 g of (trimethylsilyl) methyl 5- (1,2-dithiolan-3-yl) pentanoate (yield = 33%) is isolated.

Quasi-molecular ions [M + H] +, [M + Na] +, [M + Na + CH3OH] +, [2M + Na] + as well as the fragment [M + H-C4H12OSi] + of the expected molecule C12H24O2S2Si, M = 292 are mainly detected. The expected product is not detected in ESI-.

Calcd for C12H24O2S2Si: C 49.27, H 8.27, O 10.94, Si9.66 21.92 Found: C (49.44); H (8.3); S (21.72) 1H NMR (DMSO-d6) Signal or center signal multiplicity Integration (ppm) 0.05 s 9H 1.36 m 2H 1.55 m 3H 1.65 m 1H 1.87 m 1H 2.3 t 2H 2.4 m 1H 3.11 m 1H 3.18 Example 2 Preparation of N-bis (trimethylsilyl) methyl-5- (1,2-dithiolan-3-yl) pentanamide Compound 9 and 5- (1,2-dithiol) compounds 3-yl) -N- [3- (trimethylsilyl) propyllpentanamide (compound 10)

Synthesis of the two compounds N- [bis (trimethylsilyl) methyl] -5- (1,2-dithiolan-3-yl) pentanamide, 5- (1,2-dithiolan-3-yl) -N- [3- ( trimethylsilyl) propyl] pentanamide, is carried out from a common intermediate: 1 - {[5- (1,2-dithiolan-3-yl) pentanoyl] oxy} pyrrolidine-2,5-dione which will be described synthesis beforehand.

0. Synthesis of 1 - {[5- (1,2-dithiolan-3-yl) pentanoyl) oxy} pyrrolidine-2,5-dione In a dry 500 mL three-neck under nitrogen, surmounted by a condenser, a thermometer and an isobaric dropping funnel, 30 g (145 mmol) of 5- (1,2-dithiolan-3-yl) pentanoic acid and 16.85 g (0.145 mol) of N-hydroxysuccinimide are suspended in 200 ml. anhydrous acetonitrile. A solution of 30 g (145 mmol) of N, N'-dicyclohexylcarbodiimide in 50 mL of anhydrous acetonitrile is added dropwise at T = 0-5 ° C, then 20 mL (145 mmol) of triethylamine is added. The reaction medium is stirred at 0-5 ° C for 1 h and then left at room temperature for 24 hours.

After filtration of the white insoluble material, the reaction mixture is concentrated under vacuum P = 200 mbar at 40 ° C. and then taken up in approximately 500 ml of ethyl acetate.

The organic phase is washed with water, with a saturated solution of sodium hydrogencarbonate and with a saturated solution of sodium chloride. The organic phase is then dried over sodium sulphate, filtered and then concentrated under vacuum P = 240 mbar at 40 ° C. The crude obtained (30 g) is recrystallized under heat in 150 ml of ethanol. After drying over P2O5 under vacuum, 25.8 g of 1 - {[5- (1,2-dithiolan-3-yl) pentanoyl] oxy} pyrrolidine-2,5-dione, crystalline yellow solid, are obtained (Yield). = 60%). 1. Synthesis of N-fbis (trimethylsilyl) methyl-5- (1,2-dithiolan-3-yl) pentanamide (compound 9) In a 50 ml bicol, under nitrogen, a solution of 1.5 g is introduced ( 5 mmol) of 1 - {[5- (1,2-dithiolan-3-yl) pentanoyl] oxy} pyrrolidine-2,5-dione in 20 mL of anhydrous acetonitrile and then 0.86 g (5 mmol) of 1 , 1-bis (trimethylsilyl) methanamine and 0.68 mL (5 mmol) of triethylamine. The mixture is stirred at ambient temperature for 20 h, concentrated under vacuum P = 200 mbar at 40 ° C. and then taken up in 100 ml of dichloromethane. The organic phase is washed with water and then with a saturated solution of sodium chloride. The organic phase is then dried over sodium sulphate, filtered and then concentrated under vacuum P = 700 mbar at 40 ° C.

After purification on a silica column, eluent Heptane / ethyl acetate: 8/2, 0.68 g of N- [bis (trimethylsilyl) methyl] -5- (1,2-dithiolan-3-yl) pentanamide are obtained. yellow oil (Yield = 40%). The analysis in ESI + and ESI- makes it possible to confirm the molecular mass of the expected product C15H33NOS2Si2, M = 363 (detection of [M + H] +, [M + Na] +, [2M + Na] +, [MH] -, [M + CI] -, [2M-3H + Na] + and fragment [MH-H2S] -). Also in ESI + and ESI- are uncharacterized secondary ions of very low intensity. Analysis. calcd for C15H33NOS2Si2: C 49.5, H 9.1, N 3.9, O 4.4, S 17.6, Si 15.4. Found: C (49.90); H (9.47); N (3.75); S (17,22) 1H NMR (DMSO-d6) Signal or signal center Multiplicity Integration (ppm) 0.002 s 18H 1.35 m 2H 1.52 m 3H 1.67 m 1 H 1.86 m 1 H 2.11 t 2H 2.41 m 1 H10 3 d 1H 3.11 1. Synthesis of 5- (1,2-dithiolan-3-yl) -N- [3- (trimethylsilyl) propyl] pentanamide (Compound 10)

5- (1,2-dithiolan-3-yl) -N- [3- (trimethylsilyl) propyl] pentanamide is obtained from 3- (trimethylsilyl) propan-1-amine, the synthesis of which is described below. .

2.a. Synthesis of 3- (trimethylsilyl) propan-1-amine in two steps

In a dry, 50 mL three-necked, argon-filled, condenser and thermometer, 2.6 g (14 mmol) of potassium phthalimide was suspended in 20 mL of anhydrous N, N-dimethylformamide and 2.3 ml (13 mmol) of chloropropyltrimethylsilane are introduced dropwise into the reaction medium. The mixture is heated at T = 85 ° C. for 20 hours, allowed to return to RT and then concentrated under vacuum P = 1 mbar at 40 ° C. The crude is taken up in 100 ml of ethyl ether. After filtration of the salts, the ether phase is washed with water and then dried over sodium sulfate, filtered and concentrated under vacuum P = 700 mbar at 40 ° C. 2.7 g of 2- [3- (trimethylsilyl) propyl] -1H-isoindole-1,3 (2H) -dione are thus obtained with a yield of 71%.

For the phthalimide reduction step, 2.16 g (8.3 mmol) of 2- [3- (trimethylsilyl) propyl] -1H-isoindole-1,3 (2H) -dione are solubilized at 40 ° C in 100 ° C. mL of the isopropanol / water mixture: 6/1. At room temperature, 1.57 g (41 mmol) of sodium borohydride are gradually added and the reaction medium is stirred for 20 hours.

9 ml of acetic acid are then slowly added before refluxing for 3 hours. The reaction medium is concentrated in vacuo P = 40 mbar at 40 ° C and the residue taken up in 100 mL of water. In acid medium (pH 4-5), the aqueous phase is washed with ether, the pH brought to 12-14 with a 20% aqueous solution of ammonia and then extracted with ethyl acetate. After washing with saturated sodium chloride solution, the organic phase is dried over sodium sulfate, filtered and concentrated in vacuo. P = 240 mbar at 40 ° C.

There is thus obtained 0.5 g of 3- (trimethylsilyl) propan-1-amine (Yield = 41%). 5- (1,2-dithiolan-3-yl) -N- [3- (trimethylsilyl) propyl] pentanamide is obtained in 66% yield, introducing 1 - {[5- (1, 2-dithiolan-3-yl) pentanoyl] oxy} pyrrolidine-2,5-dione for 1 eq of 13- (trimethylsilyl) propan-1-amine. The analysis in ESI + and ESI- makes it possible to confirm the molecular mass of the expected product C14H29NOS2Si, M = 319 (detection of [M + H] +, [M + Na] +, [2M + H] +, [2M + Na] ] +, [MH] -, [M + CI] -, [M + CH3O0] - and the fragment in ESI-m / z = 272 [MH-H2S] -). Analysis. Calculated for C 14 H 29 NOS 2 Si: C 52.6, H 9.1, N 4.4, 5.0, S 20.1, Si 8.8 Found: C (52.47); H (9.10); N (4,51) 1H NMR (DMSO - d6) Signal or center signal multiplicity Integration (ppm) -0,028 s 9H 0.4 m 2H 1.35 m 4H 1.51 m 2H 1.56 m 1 H 1.65 m 1 H 1.86 m 1 H 2.04 t 2H 2.41 m 1 H 2.99 m 2 H 3.11 m 1 H 3.18 m 1 H 3.6 m 1 H 7.74 t 1 H Example 3 Preparation of 5- (1,2-dithiolan-3-yl) -N-f (trimethylsilyl) methylpentanamide (Compound 8) 1 Si-1 ss In 0.2 ml (1.5 mmol) of 1-chloro-N, N 2 -trimethylpropenylamine in a 50 ml dry beak and under argon are added dropwise to a solution of 3 g (1.5 mmol) of 5- (1,2-dithiolan-3-yl) pentanoic acid in 10 mL of anhydrous tetrahydrofuran. The reaction medium is stirred for one hour at ambient temperature and then the mixture of 0.3 ml (2.25 mmol) of aminomethyltrimethylsilane and 0.3 ml (2.25 mmol) of triethylamine is added dropwise. The mixture is stirred under magnetic stirring for 20 hours, the white insoluble material is filtered off and the filtrate is concentrated under vacuum P = 350 mbar at 40.degree. After filtration through silica eluting with dichloromethane, 0.24 g of 5- (1,2-dithiolan-3-yl) -N - [(trimethylsilyl) methyl] pentanamide (yield = 70%) are isolated.

The analysis in ESI + and ESI- makes it possible to confirm the molecular mass of the expected product C12H25NOS2Si, M = 291 (detection of [M + H] +, [M + Na] +, [2M + Na] +, [MH] -, [M + CI] -] - and fragment [MH-H2S] -). Analysis. Calcd for C12H25NOS2Si: C 49.4, H 8.6, N 4., 8.0, 5.5, Si 9.6, S22, 0 Found: C (49.24); H (8.71); N (4.76); S (22,31) 1H NMR (DMSO - d6) Signal or center signal multiplicity Integration (ppm) 0.003 s 9H 1.33 m 2H 1.49 m 2H 1.54 m 1H 1.65 m 1 H 1.85 m 1 H 2.06 t 2H 2.4 m 1 H 2.54 d 2H 3.11 m 1 H 3.17 m 1 H 3.59 m 1 H 7.56 t 1 H EXAMPLES OF FORMULATION 4 to 7 Compositions (*) 4 Ex5 Ex6 Ex7 Benzoate 10.0 10.0 10.0 10.0 Alcohols C12 / C15 Mixture mono- 6.5 6.5 6.5 6.5 glyceryl stearate / PEG stearate (100 0E) Polyacrylamide 1 0 1.0 1.0 1.0 (and) C13-C14 Isoparaffin ( and) Laureth-7 Compound 1 of _ 10.0 - - the invention Compound 8 of - - 10.0 - the invention Compound 9 of - _ - 10.0 the invention 4-Tertiobutyl-4'-1, 0 1.0 1.0 1.0 Methoxy-Dibenzoylmethan e (PARSOL 1789) Glycerin 5.0 5.0 5.0 5.0 Deionized water qsp qsp qsp 100 100 100 100 (*) excluding the invention

Photostabilization of 4- (tert-butyl) -4'-methoxy dibenzoylmethane PRINCIPLE OF THE METHOD The percentage loss of dibenzoylmethane derivative induced by exposure to a solar simulator of a formula spread in films of similar thickness is measured. from 20pm.

The evaluation is made by HPLC analysis of the filter in solution, after extraction of the films, by comparing irradiated and non-irradiated samples.

15 Material and conditions implemented

These emulsions are spread out in films of about 20 μm thick on a frosted side of a silica disc. The exact amount is determined by weighing. surface of 6 frosted quartz. 3 films are exposed to the ORIEL 20 1000W solar simulator equipped with a 4 inch output, with 81017 filter and dichroic mirror delivering a dose of 21.6 J / cm2 UVA (corresponding to a 1 hour UVA exposure). 3 other films serve as references. The samples are exposed in a horizontal position. UV-meter: OSRAM CENTRA device equipped with 2 reading heads, one for 25 UVA the other for UVB. The simulator and UV meter assembly is calibrated annually by spectroradiometry.

Irradiance measurements made at the beginning and at the end of the exposure by placing the read heads at the position of the sample. The irradiances are: 0.35 - 0.45mW / cm2 in UVB and 14 - 16 mW / cm2 in UVA

At the end of the exposure each support disk is introduced into a 600 ml jar with 10 ml of a suitable solvent (in general EtOH); the whole is placed for 5 minutes in an ultrasonic tank. The solution is then transferred to vials adapted to the support compatible with the HPLC analyzer used.

The analytical conditions can be adjusted according to the tested active.

The residual Butyl Methoxydibenzoylmethane level is measured by chromatography: HPLC chain with diode bar detector (Waters).

The residual level of Butyl Methoxydibenzoylmethane (avobenzone) is also measured after irradiation in the same support containing no dithiolane derivative compound of formula (I) (Comparative Example Formula 1).

The calculation of the residual rate (%) is carried out on the basis of the averages obtained on the samples exposed and not exposed to UV, as described below: Residual 0/0 compositions of avobenzone after exposure 1 hour UVA Ex 4 (*) 21.0 1.5 (dibenzoylmethane only) Ex 5: compound 1 95.9 2.6 EX 6: compound 8 83.1 2.8 Ex 7: compound 9 91.6 0.8 (*) Excluding the invention

Claims (15)

REVENDICATIONS1. Composition comprising in a cosmetically acceptable support at least one UV filtering system, characterized in that it comprises: at least one derivative of dibenzoylmethane and at least one silicon dithiolane compound of formula (I) below: R3 i0 D -C Si Wherein m represents an integer which may be 0, 1, 2, 3, 4, 5, 6, 7, 8, X represents an oxygen atom, nitrogen, sulfur, Y is oxygen, nitrogen, NR4 or sulfur; v is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, R1, R2, R3 represent, independently of one another, a saturated or unsaturated C 3 -C 10 linear or branched C 1 -C 10 alkyl radical which may comprise one or more halogen atoms or a phenyl radical, a benzyl radical; D denotes hydrogen, a linear C 1 -C 8 or branched C 2 -C 8 alkyl radical, saturated or unsaturated, a phenyl radical, the Si (CH 3) 3 group provided that when D is Si (CH3) 3 then v = 0 and R1, R2 and R3 are methyl; W is a linear C 1 -C 8 or branched C 3 -C 8 linear or unsaturated alkyl radical or C 2 -C 8 alkylene optionally substituted by a hydroxyl; R4 represents hydrogen, linear C1-C20 or branched C3-C20 alkyl, saturated or unsaturated, optionally substituted with an optionally substituted phenyl radical. 2. Composition according to claim 1, wherein the compound of formula (I) is chosen from those for which: m = 4; X = O; Y = OouNR4; R1 to R3 denote linear C1-C4 or branched C3-C4 alkyl which may include a phenyl radical, and more particularly methyl, ethyl, phenyl or ùCH2-Ph; R4 represents a hydrogen, a C1-C20 linear or branched C3-C20 alkyl, saturated or unsaturated, optionally substituted with an optionally substituted phenyl radical; v = 0.1 or 2; W is methylene -CH2- or -CHOH-CH2- when v is not 0; D is -H or (CH3) 3. 3. Composition according to claim 2, wherein the compound of formula (I) is chosen from those for which: m = 4; X = O; Y = OouNH; R ~ to R3 denote C1-C4 alkyl and more particularly methyl; W is methylene -CH2-. 4. Composition according to any one of claims 1 to 3, wherein the compound of formula (I) is chosen from the following compounds: No. Structure Chemical Name 1 ss 5- (1,2-dithiolan-3-yl) pentanoate of o (trimethylsilyl) methyl o-5- (1,2-dithiolan-3-yl) pentanoate o-S / 2- (trimethylsilyl) ethyl o 3 sec. 5- (1,2-dithiolan-3-yl) pentanoate 3- [trimethylsilyl] propyl] -4- [5- (1,2-dithiolan-3-yl) pentanoate] ethyl (dimethyl) silyl 2-Hydroxy-3- (tri-methylsilyl) -propyl-6-methyl-5- (1,2-dithiolan-3-yl) -methyl-5- (1,2-dithiolan-3-yl) pentanoate pentanoate of fis; [(benzyl (dimethyl) silyl] methyl [8-dimethyl (phenyl) silyl] methyl] [5- [1,2-dithiolan-3-yl] pentanoate] pentanoate [5- (1,2-dithiolan-3)] N-[bis (trimethylsilyl) methyl] -5- (1,2-N-dithiolan-3-yl) pentanamide [N- [(trimethylsilyl) methyl] pentanamide (1,2-dithiolan-3-yl) -N- [3-. (trimethylsilyl) propyl] pentanamide o. A composition according to claim 4, wherein the compound of compounds of formula (I) is selected from compounds 1, 8 and 9: 6. Composition according to any one of claims 1 to 5, wherein the dibenzoylmethane derivative is 4- (tert-butyl) -4'-methoxy dibenzoylmethane or butyl methoxy dibenzoylmethane of the following formula: embedded image 7. Composition according to any one of claims 1 to 6, characterized in that it contains in addition to other organic or inorganic filters active in UV-A and / or UV-B water-soluble or fat-soluble or insoluble in commonly used cosmetic solvents. 8. The composition of claim 7, wherein the complementary organic filters are selected from anthranilates; cinnamic derivatives; salicylic derivatives, camphor derivatives; benzophenone derivatives; 1,3,13-diphenylacrylate derivatives; triazine derivatives; benzotriazole derivatives; benzalmalonate derivatives; benzimidazole derivatives; imidazolines; bis-benzoazolyl derivatives; p-aminobenzoic acid derivatives (PABA); methylene bis (hydroxyphenyl benzotriazole) derivatives; benzoxazole derivatives; filter polymers and silicone filters; dimers derived from α-alkylstyrene; 4,4-diarylbutadienes; merocyanine derivatives and mixtures thereof. 25 9. Composition according to Claim 8, characterized in that the organic UV screening agent or filters are chosen from the following compounds: ethylhexyl methoxycinnamate ethylhexyl salicylate, homosalate, octocrylene, phenylbenzimidazole sulphonic acid, benzophenone-3, benzophenone-4, benzophenone- 5, N-Hexyl 2- (4-diethylamino-2-hydroxybenzoyl) benzoate. 4-Methylbenzylidene camphor, Terephthalylidene Dicamphor Sulfonic Acid, Disodium Phenyl Dibenzimidazole Tetra-sulfonate, Methylene bis-Benzotriazolyl Tetramethylbutylphenol 40 Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine Ethylhexyl triazone, Diethylhexyl Butamido Triazone, 2,4,6-Tris (4'-amino benzalmalonate) dineopentyl) -s-triazine 2,4,6-tris- (4'-amino benzalmalonate diisobutyl) -s-triazine 45 2,4bis (n-butyl 4-aminobenzoate) -6- (aminopropyltrisiloxane) s-triazine, 2,4bis (dineopentyl 4'-aminobenzalmalonate) -6- (n-butyl 4'-aminobenzoate) -s-triazine, 2,4,6-tris (biphenyl-4-yl-1,3) 2,4,6-tris (terphenyl) -1,3,5-triazine, 5-triazine Drometrizole Trisiloxane Polysilicone-1,1-dicarboxy (2,2'-dimethyl-propyl) -4,4-diphenylbutadiene 2 4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) imino] -6- (2-ethylhexyl) imino-1,3,5-triazine Octyl-5-N N-diethylamino-2-phenysulfonyl-2,4-pentadienoate and mixtures thereof. 10. Composition according to claim 7, characterized in that the complementary inorganic filters are metallic oxide pigments, coated or uncoated. 11. The composition of claim 10, wherein the coated or uncoated metal oxide pigments have a mean primary particle size: between 5 nm and 100 nm and preferably between 10 nm and 50 nm. 12. Composition according to claim 10 or 11, in which the pigments of coated or uncoated metal oxides are chosen from titanium oxide pigments (amorphous or crystallized in rutile and / or anatase form), iron, zinc, zirconium or cerium or their mixtures. 13. Composition according to any one of claims 1 to 12, characterized in that it is in the form of an oil-in-water or water-in-oil emulsion. 30 14. Process for improving the chemical stability with respect to the UV radiation of at least one dibenzoylmethane derivative as defined in any one of the preceding claims, characterized by the fact that said dibenzoylmethane derivative is associated with a quantity of dibenzoylmethane. effective of at least one silicon dithiolane compound of formula (I) as defined in the preceding claims. 15. Use of at least one silicon dithiolane compound of formula (I) as defined in the preceding claims in a composition comprising 40 in a cosmetically acceptable support, at least one derivative of dibenzoylmethane as defined in any one of the claims. for the purpose of improving the effectiveness of said composition vis-à-vis UV-A. 20 25